<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Nat Commun</journal-id>
<journal-id journal-id-type="iso-abbrev">Nat Commun</journal-id>
<journal-title-group>
<journal-title>Nature Communications</journal-title>
</journal-title-group>
<issn pub-type="epub">2041-1723</issn>
<publisher>
<publisher-name>Nature Publishing Group UK</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30150678</article-id>
<article-id pub-id-type="pmc">6110722</article-id>
<article-id pub-id-type="publisher-id">5595</article-id>
<article-id pub-id-type="doi">10.1038/s41467-018-05595-6</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title><italic>MAP1B</italic> mutations cause intellectual disability and extensive white matter deficit</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Walters</surname>
<given-names>G. Bragi</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gustafsson</surname>
<given-names>Omar</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sveinbjornsson</surname>
<given-names>Gardar</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0110-1877</contrib-id>
<name>
<surname>Eiriksdottir</surname>
<given-names>Valgerdur K.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Agustsdottir</surname>
<given-names>Arna B.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jonsdottir</surname>
<given-names>Gudrun A.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7726-5152</contrib-id>
<name>
<surname>Steinberg</surname>
<given-names>Stacy</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gunnarsson</surname>
<given-names>Arni F.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Magnusson</surname>
<given-names>Magnus I.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Unnsteinsdottir</surname>
<given-names>Unnur</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Amy L.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jonasdottir</surname>
<given-names>Adalbjorg</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sigurdsson</surname>
<given-names>Asgeir</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jonasdottir</surname>
<given-names>Aslaug</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Skuladottir</surname>
<given-names>Astros</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jonsson</surname>
<given-names>Lina</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5576-9007</contrib-id>
<name>
<surname>Nawaz</surname>
<given-names>Muhammad S.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7123-6123</contrib-id>
<name>
<surname>Sulem</surname>
<given-names>Patrick</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Frigge</surname>
<given-names>Mike</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ingason</surname>
<given-names>Andres</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Love</surname>
<given-names>Askell</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Norddhal</surname>
<given-names>Gudmundur L.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zervas</surname>
<given-names>Mark</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5222-9857</contrib-id>
<name>
<surname>Gudbjartsson</surname>
<given-names>Daniel F.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0461-040X</contrib-id>
<name>
<surname>Ulfarsson</surname>
<given-names>Magnus O.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6912-5846</contrib-id>
<name>
<surname>Saemundsen</surname>
<given-names>Evald</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9331-6666</contrib-id>
<name>
<surname>Stefansson</surname>
<given-names>Hreinn</given-names>
</name>
<address>
<email>hreinn@decode.is</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Stefansson</surname>
<given-names>Kari</given-names>
</name>
<address>
<email>kstefans@decode.is</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<aff id="Aff1"><label>1</label>deCODE genetics/Amgen, Reykjavik, 101 Iceland </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0640 0021</institution-id><institution-id institution-id-type="GRID">grid.14013.37</institution-id><institution>Faculty of Medicine, </institution><institution>University of Iceland, </institution></institution-wrap>Reykjavik, 101 Iceland </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9919 9582</institution-id><institution-id institution-id-type="GRID">grid.8761.8</institution-id><institution>Department of Pharmacology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, </institution><institution> University of Gothenburg, </institution></institution-wrap>Gothenburg, 405 30 Sweden </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9894 0842</institution-id><institution-id institution-id-type="GRID">grid.410540.4</institution-id><institution>Department of Radiology, </institution><institution>Landspitali University Hospital, Fossvogur, </institution></institution-wrap>Reykjavik, 108 Iceland </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0640 0021</institution-id><institution-id institution-id-type="GRID">grid.14013.37</institution-id><institution>School of Engineering and Natural Sciences, </institution><institution>University of Iceland, </institution></institution-wrap>Reykjavik, 101 Iceland </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0640 0021</institution-id><institution-id institution-id-type="GRID">grid.14013.37</institution-id><institution>Faculty of Electrical and Computer Engineering, </institution><institution>University of Iceland, </institution></institution-wrap>Reykjavik, 101 Iceland </aff>
<aff id="Aff7"><label>7</label>The State Diagnostic and Counselling Centre, Kopavogur, 200 Iceland </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>27</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>27</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>9</volume>
<elocation-id>3456</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>2</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>7</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Â© The Author(s) 2018</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the articleâs Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the articleâs Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Discovery of coding variants in genes that confer risk of neurodevelopmental disorders is an important step towards understanding the pathophysiology of these disorders. Whole-genome sequencing of 31,463 Icelanders uncovers a frameshift variant (E712KfsTer10) in <italic>microtubule-associated protein 1B</italic> (<italic>MAP1B</italic>) that associates with ID/low IQ in a large pedigree (genome-wide corrected <italic>P</italic>â=â0.022). Additional stop-gain variants in <italic>MAP1B</italic> (E1032Ter and R1664Ter) validate the association with ID and IQ. Carriers have 24% less white matter (WM) volume (<italic>Î²</italic>â=ââ2.1SD, <italic>P</italic>â=â5.1âÃâ10<sup>â8</sup>), 47% less corpus callosum (CC) volume (<italic>Î²</italic>â=ââ2.4SD, <italic>P</italic>â=â5.5âÃâ10<sup>â10</sup>) and lower brain-wide fractional anisotropy (<italic>P</italic>â=â6.7âÃâ10<sup>â4</sup>). In summary, we show that loss of MAP1B function affects general cognitive ability through a profound, brain-wide WM deficit with likely disordered or compromised axons.</p>
</abstract>
<abstract abstract-type="web-summary" id="Abs2">
<p id="Par2">Intellectual disability (ID) is characterized by an intelligence quotient of below 70 and impaired adaptive skills. Here, analyzing whole genome sequences from 31,463 Icelanders, Walters et al. identify variants in MAP1B associated with ID and extensive brain-wide white matter deficits.</p>
</abstract>
<funding-group>
<award-group>
<funding-source>
<institution>L.J. received support from the Swedish Society of Medicine, the Swedish Brain Foundation and Swedish Society for Medical Research</institution>
</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100004963</institution-id>
<institution>EC | Seventh Framework Programme (European Union Seventh Framework Programme)</institution>
</institution-wrap>
</funding-source>
<award-id>602450</award-id>
<award-id>286213</award-id>
<principal-award-recipient>
<name>
<surname>Stefansson</surname>
<given-names>Hreinn</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreementsâ no. 115008 (NEWMEDS) and no. 115300 (EUAIMS) of which resources are composed of EFPIA in-kind contribution and financial contribution from the European Unionâs Seventh Framework Programme (EU-FP7/2007-2013), EU-FP7 funded grant no. 602450 (IMAGEMEND) and EU funded FP7-People-2011-IAPP grant agreement no. 286213 (PsychDPC).</institution>
</funding-source>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>Â© The Author(s) 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Introduction</title>
<p id="Par3">ID refers to a group of aetiologically diverse conditions, resulting in below average cognitive abilities. Affected individuals are typically identified in childhood due to delay in developmental milestones. A formal diagnosis of ID is made when an intelligence quotient (IQ) of less than 70, on a normal distribution with a mean of 100 and standard deviation of 15, is coupled with impairments in adaptive function including conceptual, social and practical skills (APA URL)<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. A full-scale IQ (FSIQ) score is calculated from subtests grouped into two general areas, verbal and performance related tasks, which can be discrepant in some disorders<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR3">3</xref></sup>. While ID negatively affects fecundity, de novo mutations maintain ID sequence variants in the population<sup><xref ref-type="bibr" rid="CR4">4</xref></sup> and heritability estimates are higher for mild than for severe ID<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>.</p>
<p id="Par4">Numerous genes have been implicated across a wide spectrum of syndromic and non-syndromic forms of ID and a significant overlap noted with genes identified in other neurodevelopmental disorders including ASD<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. Large-scale next-generation sequencing efforts of individuals with developmental disorders<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>, ID<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup> and ASD<sup><xref ref-type="bibr" rid="CR10">10</xref></sup> have made significant contributions to the understanding of their pathogenesis. Bioinformatics and functional analyses have grouped some of the ID genes into common pathways, representing regulation of transcription and translation, neurogenesis and neuronal migration and synaptic function and plasticity<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>.</p>
<p id="Par5">Utilising next-generation sequencing to search for variants in genes important for brain development and function combined with psychological assessment and brain structural traits in carriers, could provide a better understanding of the molecular processes and neuronal connectivity underlying cognitive diversity in neurodevelopmental disorders. Here we describe three variants in the <italic>MAP1B</italic> gene, which truncate the protein, segregating with ID and low IQ. Furthermore, carriers have significantly less white matter (WM) volume and a decrease in fractional anisotropy (FA), suggesting disordered or compromised axons.</p>
</sec>
<sec id="Sec2" sec-type="results">
<title>Results</title>
<sec id="Sec3">
<title>Genome-wide scan for high-impact variants</title>
<p id="Par6">We recruited an extended pedigree with ID for cognitive phenotyping, brain imaging and whole-genome sequencing (WGS) (Fig.Â <xref ref-type="fig" rid="Fig1">1a</xref> and Supplementary TableÂ <xref ref-type="media" rid="MOESM1">1</xref>). In this family there are five individuals with diagnosed ID and three of their relatives, without a clinical diagnosis, with IQ below 70. We applied a recently described statistical procedure<sup><xref ref-type="bibr" rid="CR12">12</xref></sup> to estimate the intra-family association, of genome-wide, rare, coding variants, with diagnosed ID or IQ below 70. Only one variant, a frameshift variant causing premature truncation (E712KfsTer10) of <italic>MAP1B</italic> (Supplementary FigureÂ <xref ref-type="media" rid="MOESM1">1</xref>) was found to associate with the cognitive impairments in this family (genome-wide corrected <italic>P</italic>â=â0.022).<fig id="Fig1"><label>Fig. 1</label><caption><p>Pedigree plots for <italic>MAP1B</italic> LoF carrier families. <bold>a</bold> Family 1 (FAM1)âE712KfsTer10 (c.2133delG), <bold>b</bold> Family 2 (FAM2)âE1032Ter (c.3094âGâ&gt;âT) and <bold>c</bold> Family 3 (FAM3)âR1664Ter (c.4990âCâ&gt;âT). Squares are male, circles are female, diamonds are where gender is withheld, unfilled are unaffected, filled with black are intellectual disability affected, half black and white are individuals without a clinical diagnosis but an IQ below 70, blue are Autism spectrum disorder affected and yellow and white squares within the pedigree symbol indicates where it is most likely the initial <italic>MAP1B</italic> LoF mutation event occurred. Below each icon is the subjects: alias; <italic>MAP1B</italic> LoF variant genotype; Full-scale IQ (Verbal IQ/Performance IQ) from WASI<sup>IS</sup> or WPPSI-R (FAM1-B1,-B3,-C1,-C2,-D1,-D2,-D3; FAM2-H1,-H2,-J2; FAM3-K1,-K2,-L1 or FAM1-D5,-E1, respectively), or only Full-scale IQ reported from WISC-IV (FAM1-D4, FAM2-J1,-J3 and FAM3-M1), and corpus callosum (CC) volume (all individuals with structural MRI also have DTI except FAM1-C1). Refer to Supplementary FigureÂ <xref ref-type="media" rid="MOESM1">2</xref> for a description of how the de novo event carriers were identified</p></caption><graphic id="d29e628" xlink:href="41467_2018_5595_Fig1_HTML"></graphic></fig></p>
<p id="Par7">The E712KfsTer10 variant is carried by eight members of this family, seven with ID or IQ below 70, and not found in any of the other 31,463 WGS Icelanders. The eighth carrier (FAM1-A1) is deceased, and so cognitive assessment could not be performed. We note a noncarrier, in this family, with a diagnosis of ID (FAM1-D4). As the E712KfsTer10 variant results in cognitive impairments a carrier is likely to find a partner with comparable cognitive abilities. This may introduce, into the family, a mixture of rare and common markers conferring risk of cognitive deficits.</p>
</sec>
<sec id="Sec4">
<title>MAP1B association with ID confirmed</title>
<p id="Par8">We searched for additional <italic>MAP1B</italic> LoF variants in the 31,463 WGS Icelanders, of whom 408 carry the diagnosis of ID, and found two stop-gain variants, E1032Ter and R1664Ter (Supplementary FigureÂ <xref ref-type="media" rid="MOESM1">1</xref>). The E1032Ter variant was found in four individuals: three siblings and their mother (Fig.Â <xref ref-type="fig" rid="Fig1">1b</xref> and Supplementary TableÂ <xref ref-type="media" rid="MOESM1">1</xref>). Two of the three siblings have atypical autism and a FSIQ below 70. Both have higher verbal IQ (VIQ) than performance IQ (PIQ) and a cognitive profile consistent with non-verbal learning disorder (NVLD)<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. The third sibling with a FSIQ of 79, reported having dyscalculia and dyslexia, while their mother has a FSIQ of 77 (VIQ higher than PIQ). The R1664Ter variant was found in two individuals, a mother with a FSIQ of 92 (VIQ 105, PIQ 82) and her daughter with a diagnosis of Asperger syndrome and a FSIQ of 76 (Fig.Â <xref ref-type="fig" rid="Fig1">1c</xref> and Supplementary TableÂ <xref ref-type="media" rid="MOESM1">1</xref>).</p>
<p id="Par9">Hence, together the E1032Ter and R1664Ter variants are carried by two ID cases and four of their relatives without an ID diagnosis, but have an average IQ score of 81. Regressing the allele carrier status, for either LoF variant, on the ID status or IQ scores, further confirmed the association with LoF variants in <italic>MAP1B</italic> (ORâ=â69.6, <italic>P</italic>â=â4.9âÃâ10<sup>â4</sup> and Effect (IQ score)â=ââ23.07, <italic>P</italic>â=â1.4âÃâ10<sup>â3</sup>, respectively; Methods). This establishes that LoF variants in <italic>MAP1B</italic> associate strongly with cognitive impairments.</p>
<p id="Par10">We also evaluated anthropometric traits including head circumference, height and weight and found no association with <italic>MAP1B</italic> LoF carrier status, after adjusting for relatedness (<italic>P</italic>â=â0.16, 0.98, 0.56, respectively; Supplementary TableÂ <xref ref-type="media" rid="MOESM1">2</xref>).</p>
</sec>
<sec id="Sec5">
<title>MAP1B variants in public databases</title>
<p id="Par11">The three <italic>MAP1B</italic> LoF variants, described here, have not been previously reported (Supplementary TableÂ <xref ref-type="media" rid="MOESM1">3</xref>) and were not observed in any of the publicly available databases (Supplementary TableÂ <xref ref-type="media" rid="MOESM1">4</xref>), which is consistent with their rarity in Iceland. Furthermore, the Exome Aggregation Consortium (ExAc, URL)<sup><xref ref-type="bibr" rid="CR14">14</xref></sup> estimated a very-high probability of LoF intolerance for <italic>MAP1B</italic>, suggesting that LoF mutations in <italic>MAP1B</italic> reduce fitness. However, LoF variants in <italic>MAP1B</italic> are found in publicly available databases at a frequency of 1 in 10,000. ExAc also classify missense variants in <italic>MAP1B</italic> to be under modest constraint. However, we do not observe any <italic>MAP1B</italic> missense variants in individuals with ID or ASD.</p>
<p id="Par12">Copy number variations spanning <italic>MAP1B</italic> have also been reported in individuals where the most frequently described trait is ID or developmental delay (Supplementary TableÂ <xref ref-type="media" rid="MOESM1">5</xref>). A single individual with a deletion spanning <italic>MAP1B</italic> was identified in a sample of 157,065 Icelandic genotyped subjects. This deletion carrier has severe ID (FAM4; Supplementary TableÂ <xref ref-type="media" rid="MOESM1">1</xref>).</p>
</sec>
<sec id="Sec6">
<title>MAP1B carriers show general cognitive impairments</title>
<p id="Par13">Overall, the <italic>MAP1B</italic> LoF carriers (<italic>n</italic>â=â13) have lower FSIQ than noncarriers (<italic>P</italic>â=â8.2âÃâ10<sup>â6</sup>, TableÂ <xref ref-type="table" rid="Tab1">1</xref> and Supplementary FigureÂ <xref ref-type="media" rid="MOESM1">3</xref>) and a paired test revealed higher VIQ than PIQ (<italic>P</italic>â=â0.042, two-tailed, Studentâs <italic>t</italic>-test), mainly due to the lower Block Design subtest. A comparable difference between VIQ and PIQ scores has been reported in disorders that include NVLD like symptoms, including autism spectrum disorder (ASD)<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>, Fragile X syndrome<sup><xref ref-type="bibr" rid="CR13">13</xref></sup> and agenesis of corpus callosum (AgCC)<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>IQ scores for <italic>MAP1B</italic> LoF carriers compared with controls</p></caption><table frame="hsides" rules="groups"><thead><tr><th>IQ</th><th><italic>n</italic> (MAP1BâCarriers/Controls)</th><th>Mean (SD) (<italic>MAP1B</italic>âCarriers/Controls)</th><th><italic>Î²</italic> (95% CI)</th><th>
<italic>P</italic>
</th></tr></thead><tbody><tr><td>Full-scale IQ</td><td>13/2226</td><td>68.3 (10.5)/102.1 (14.9)</td><td>â1.6 (â2.3, â0.9)</td><td>8.2âÃâ10<sup>â6</sup></td></tr><tr><td>ââââPerformance IQ</td><td>10/2226</td><td>66.4 (9.3)/99.8 (15.2)</td><td>â1.6 (â2.4, â0.8)</td><td>6.4âÃâ10<sup>â5</sup></td></tr><tr><td>ââââââââBlock design</td><td>9/1768</td><td>27.6 (5.8)/49.4 (10.5)</td><td>â1.7 (â2.5, â0.9)</td><td>3.1âÃâ10<sup>â5</sup></td></tr><tr><td>ââââââââMatrix reasoning</td><td>9/1768</td><td>31.4 (7.5)/49.7 (10.0)</td><td>â1.0 (â1.8, â0.2)</td><td>0.014</td></tr><tr><td>ââââVerbal IQ</td><td>10/2226</td><td>74.5 (14.8)/103.5 (15.0)</td><td>â1.2 (â2.0, â0.4)</td><td>0.0039</td></tr><tr><td>ââââââââVocabulary</td><td>9/1767</td><td>33.2 (11.8)/52.3 (9.5)</td><td>â1.1 (â1.9, â0.3)</td><td>0.0082</td></tr><tr><td>ââââââââSimilarities</td><td>9/1768</td><td>34.0 (10.8)/51.5 (9.7)</td><td>â1.0 (â1.8, â0.2)</td><td>0.016</td></tr></tbody></table><table-wrap-foot><p>The IQ tests values are unadjusted means and standard deviation (SD). For analyses, the IQ test scores were inverse normal transformed, then shifted and scaled, resulting in controls having a mean of 0 and a standard deviation of 1. Lower IQ scores represent greater impairment in <italic>MAP1B</italic> LoF carriers. The effects (Î² in SD) and <italic>P-</italic>values were calculated by comparing <italic>MAP1B</italic> LoF carriers (FAM1-B1,-C1,-C2,-D1,-D2,-D3, FAM2-H1,-J2, FAM3-L1) with controls using a generalised least-squares regression with a varianceâcovariance matrix based on the kinship coefficient of each pair of individuals</p><p>SD: standard deviation</p></table-wrap-foot></table-wrap></p>
<p id="Par14"><italic>MAP1B</italic> LoF carriers and noncarrier relatives were administered a battery of neuropsychological tests gauging aspects of executive function, memory, attention and fluency<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. As expected from the IQ assessment, <italic>MAP1B</italic> LoF carriers performed poorly on all cognitive tasks, in particular they recalled fewer words in the letter fluency test (LF) and performed slower on the trail-making test part A (TMT-A) (TableÂ <xref ref-type="table" rid="Tab2">2</xref>). Notably, <italic>MAP1B</italic> LoF carriers also made more mistakes on the emotion recognition task (ERT-Cor), a test of a form of social cognition, where comparable impairments are described in ASD<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>, AgCC<sup><xref ref-type="bibr" rid="CR18">18</xref></sup> and NVLD<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. The MINI<sup><xref ref-type="bibr" rid="CR19">19</xref></sup> interview did not reveal any psychiatric disorders and overall social and occupational functioning according to the global assessment of functioning scale (GAF)<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> gave comparable scores for carriers and noncarriers (<italic>P</italic>â=â0.69) (TableÂ <xref ref-type="table" rid="Tab2">2</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Cognitive assessment test scores for <italic>MAP1B</italic> LoF carriers compared with controls</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Cognitive test</th><th><italic>n</italic> (<italic>MAP1B</italic>âCarriers/Controls)</th><th>Mean (SD) (<italic>MAP1B</italic>âCarriers/Controls)</th><th><italic>Î²</italic> (95% CI)</th><th>
<italic>P</italic>
</th></tr></thead><tbody><tr><td>LMI&amp;II</td><td>9/2230</td><td>65.9 (22.5)/68.6 (17.3)</td><td>0.3 (â0.5, 1.1)</td><td>0.45</td></tr><tr><td>LF</td><td>9/2221</td><td>16 (8.5)/29.3 (9.5)</td><td>1.2 (0.4, 2.1)</td><td>0.0037</td></tr><tr><td>CF</td><td>9/2224</td><td>17.2 (5.6)/22.0 (5.5)</td><td>0.8 (â0.01, 1.6)</td><td>0.053</td></tr><tr><td>Stroop</td><td>8/2218</td><td>48.8 (31.5)/26.6 (12.3)</td><td>1.0 (0.2, 1.9)</td><td>0.018</td></tr><tr><td>TMT</td><td>8/2207</td><td>82.8 (75.5)/44.8 (26.2)</td><td>0.8 (â0.1, 1.6)</td><td>0.065</td></tr><tr><td>Pers. err</td><td>9/2175</td><td>24.1 (15.2)/14.7 (12.3)</td><td>0.9 (0.1, 1.8)</td><td>0.031</td></tr><tr><td>SWM</td><td>9/2208</td><td>6.2 (5.1)/6.3 (7.2)</td><td>0.9 (0.1, 1.8)</td><td>0.026</td></tr><tr><td>RVIP</td><td>7/1964</td><td>0.9 (0.05)/0.9 (0.1)</td><td>0.9 (0.1, 1.8)</td><td>0.029</td></tr><tr><td>TMT-A</td><td>8/2218</td><td>42.2 (15.8)/29.6 (12.8)</td><td>1.2 (0.4, 2.1)</td><td>0.0046</td></tr><tr><td>Str-bl</td><td>8/2223</td><td>22.9 (4.1)/21.3 (4.4)</td><td>0.2 (â0.7, 1.0)</td><td>0.72</td></tr><tr><td>ERT-Cor</td><td>6/788</td><td>0.5 (0.2)/0.6 (0.1)</td><td>1.5 (0.5, 2.5)</td><td>0.0042</td></tr><tr><td>ERT-Lat</td><td>6/788</td><td>1912.3 (559.9)/1994.6 (680.2)</td><td>0.5 (â0.5, 1.5)</td><td>0.35</td></tr><tr><td>GAF</td><td>9/2153</td><td>80.7 (4.6)/80.9 (10.0)</td><td>0.2 (â0.7, 1.0)</td><td>0.69</td></tr></tbody></table><table-wrap-foot><p>The cognitive assessment values are unadjusted means and SD. For analyses the cognitive test scores were inverse normal transformed and adjusted for sex, age and age<sup>2</sup>. Cognitive test scores were then shifted and scaled, resulting in controls having a mean of 0 and a standard deviation of 1. The cognitive test scores were arranged such that higher scores indicate greater impairment, in <italic>MAP1B</italic> LoF carriers. The effects (Î² in SD) and <italic>P</italic>-values were calculated by comparing <italic>MAP1B</italic> LoF carriers (FAM1-B1,-C1,-C2,-D1,-D2,-D3, FAM2-H1,-J2, FAM3-L1) with controls using a generalised least-squares regression with a varianceâcovariance matrix based on the kinship coefficient of each pair of individuals. See Methods for a description of the cognitive tests</p><p>LMI&amp;II: logical memory subtest from the Wechsler Memory Scale III (WMS-III), LF: letter fluency from the controlled oral word association test (COWAT), CF: category fluency from the category naming test, Stroop: name colour minus colour pad task, TMT: trail-making test (refers to part B minus part A), Pers. err.: perseverative error from the Wisconsin card-sorting test (WCST), SWM: spatial working memory, RVIP: rapid visual information processing, TMT-A: trail-making test part A, Str-bl: stroop black letter, ERT-Cor: emotion recognition task-percentage correct, ERT-Lat: emotion recognition task-mean response latency, SD: standard deviation, GAF: global assessment of functioning scale</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec7">
<title>IQ and education polygenic score in MAP1B carriers</title>
<p id="Par15">Combining the effect sizes from a genome-wide association study (GWAS) to generate a polygenic score (PGS) is beginning to play a role in predicting differences in complex traits such as intelligence<sup><xref ref-type="bibr" rid="CR21">21</xref></sup> and educational attainment<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. We used summary statistics from a recent GWAS for IQ<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> and educational attainment<sup><xref ref-type="bibr" rid="CR24">24</xref></sup> to determine the per-locus allele-specific weightings of markers used to calculate a PGS for IQ (PGS-IQ) and educational attainment (PGS-EDU), respectively (Methods and References<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>). We compared the PGS-IQ and PGS-EDU in <italic>MAP1B</italic> carriers (<italic>n</italic>â=â13) to controls (<italic>n</italic>â=â2164) and found no significant difference (<italic>P</italic>â=â0.20 and 0.82, respectively; Welch Two Sample <italic>t</italic>-test) (Supplementary FigureÂ <xref ref-type="media" rid="MOESM1">4</xref> and Supplementary FigureÂ <xref ref-type="media" rid="MOESM1">5</xref>).</p>
</sec>
<sec id="Sec8">
<title>Brain structure affected by MAP1B variants</title>
<p id="Par16">Brain MRI scans were obtained of ten <italic>MAP1B</italic> LoF carriers. They have a smaller corpus callosum (CC) and less brain-wide WM volume (<italic>Î²</italic>â=ââ2.4âSD, <italic>P</italic>â=â5.5âÃâ10<sup>â10</sup>and <italic>Î²</italic>â=ââ2.1âSD, <italic>P</italic>â=â5.1âÃâ10<sup>â8</sup>, respectively) than noncarriers (<italic>n</italic>â=â949) (TableÂ <xref ref-type="table" rid="Tab3">3</xref>, Fig.Â <xref ref-type="fig" rid="Fig2">2</xref> and Supplementary DataÂ <xref ref-type="media" rid="MOESM3">1</xref>). This corresponds to a CC and WM volume deficit of 47 and 24%, respectively. Noncarrier relatives (<italic>n</italic>â=â5) have mean CC and WM volumes (â0.53 (SD 0.72) and â0.88 (SD 0.97), respectively) indistinguishable from controls (<italic>P</italic>â=â0.22 and 0.043, respectively) (Supplementary FigureÂ <xref ref-type="media" rid="MOESM1">6</xref>). The association between the <italic>MAP1B</italic> LoF variants and smaller CC and brain-wide WM volume is consistent with published findings in mouse <italic>MAP1B</italic> knockouts, where AgCC, enlargement of the lateral and third ventricles, and abnormal structures of the cortex, cerebellum and hippocampus have been described<sup><xref ref-type="bibr" rid="CR26">26</xref>â<xref ref-type="bibr" rid="CR28">28</xref></sup>.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Brain white matter differences in <italic>MAP1B</italic> LoF carriers compared with controls</p></caption><table frame="hsides" rules="groups"><thead><tr><th>White matter</th><th>MAP1B-FS</th><th>Controls-FS</th><th><italic>Î²</italic> (95% CI)</th><th>
<italic>P</italic>
</th></tr></thead><tbody><tr><td>Corpus callosumâanteriorâvolume</td><td>431.3 (155.9)</td><td>900.2 (153.7)</td><td>â2.6 (â3.4, â1.9)</td><td>1.9âÃâ10<sup>â11</sup></td></tr><tr><td>Corpus callosumâposteriorâvolume</td><td>472.9 (141.4)</td><td>988.6 (156.7)</td><td>â2.5 (â3.3, â1.8)</td><td>1.0âÃâ10<sup>â10</sup></td></tr><tr><td>Corpus callosumâtotalâvolume</td><td>1689.3 (426.4)</td><td>3210.3 (486.3)</td><td>â2.4 (â3.2, â1.7)</td><td>5.5âÃâ10<sup>â10</sup></td></tr><tr><td>LHâCerebral white matterâvolume</td><td>190965.3 (23104.5)</td><td>250084.3 (30115.5)</td><td>â2.2 (â2.9, â1.4)</td><td>4.0âÃâ10<sup>â08</sup></td></tr><tr><td>Total cerebral white matterâvolume</td><td>382905.6 (46892.5)</td><td>502178.8 (60387.8)</td><td>â2.1 (â2.9, â1.4)</td><td>5.1âÃâ10<sup>â08</sup></td></tr><tr><td>RHâcerebral white matterâvolume</td><td>191940.3 (23831.4)</td><td>252094.6 (30354.8)</td><td>â2.1 (â2.9, â1.3)</td><td>6.8âÃâ10<sup>â08</sup></td></tr><tr><td>Corpus callosumâcentralâvolume</td><td>268.2 (56.6)</td><td>438 (87.7)</td><td>â1.9 (â2.7, â1.1)</td><td>1.1âÃâ10<sup>â06</sup></td></tr><tr><td>Corpus callosumâmid-posteriorâvolume</td><td>245.2 (60.4)</td><td>424.7 (92.3)</td><td>â1.8 (â2.6, â1.0)</td><td>4.7âÃâ10<sup>â06</sup></td></tr><tr><td>Corpus callosumâmid-anteriorâvolume</td><td>271.8 (80.5)</td><td>458.8 (103.6)</td><td>â1.8 (â2.5, â1.0)</td><td>4.8âÃâ10<sup>â06</sup></td></tr><tr><td>LHâwhite matter surface area</td><td>75187.5 (8576.7)</td><td>85866.9 (8321.5)</td><td>â1.5 (â2.3, â0.8)</td><td>7.9âÃâ10<sup>â05</sup></td></tr><tr><td>RHâwhite matter surface area</td><td>75488.3 (8865.8)</td><td>86285.6 (8411.9)</td><td>â1.5 (â2.3, â0.8)</td><td>8.3âÃâ10<sup>â05</sup></td></tr></tbody></table><table-wrap-foot><p>The MAP1B-FS and Control-FS are unadjusted mean and SD MRI white matter volume (mm<sup>3</sup>) and grey matter volume (mm<sup>3</sup>), surface area (mm<sup>2</sup>) and thickness (mm) values derived from FS. Individualsâ FS values were inverse normal transformed and adjusted for sex, age, age<sup>2</sup>, scanner model and ICV where appropriate. The effect (<italic>Î²</italic> in SD) and <italic>P</italic>-value were calculated by comparing <italic>MAP1B</italic> LoF carriers (<italic>n</italic>â=â10; FAM1-B1,-C1,-C2,-D1,-D2,-D3, FAM2-H1,-J1,-J2, FAM3-L1) with controls (<italic>n</italic>â=â949) using a generalised least-squares regression with a varianceâcovariance matrix based on the kinship coefficient of each pair of individuals. See Supplementary DataÂ <xref ref-type="media" rid="MOESM3">1</xref> for the full list of 274 traits. Bonferroni significance level was set at 0.05/274â=â1.8âÃâ10<sup>â4</sup></p><p>LH: left hemisphere, RH: right hemisphere, SD: standard deviation, FS: FreeSurfer</p></table-wrap-foot></table-wrap><fig id="Fig2"><label>Fig. 2</label><caption><p>CC and WM volume differences in <italic>MAP1B</italic> LoF carriers compared with controls. <bold>a</bold> The colour scales refer to regions that are smaller (blue) or larger (red/yellow) in <italic>MAP1B</italic> LoF carriers (<italic>n</italic>â=â10) compared with controls (<italic>n</italic>â=â949). See TablesÂ <xref ref-type="table" rid="Tab3">3</xref> and <xref ref-type="table" rid="Tab4">4</xref> for details. The four brain aspects in the left of the figure are from top left and clockwise: left hemisphere (LH) lateral surface, right hemisphere (RH) lateral surface, RH medial surface and LH medial surface. The middle image is an axial slice with the front of the brain at the top of the figure and demonstrates the ubiquitous nature of the WM and GM effects; R is right and L is left. The image on the right is a glass brain highlighting the significant reduction in WM in the corpus callosum. <bold>b</bold> Unadjusted corpus callosum and cerebral WM volumes plotted against intracranial volume (ICV) from FreeSurfer (in mm<sup>3</sup>) for <italic>MAP1B</italic> LoF carriers (blue) compared with controls (grey). Relative to the linear regression (diagonal line) the <italic>MAP1B</italic> LoF carriers have smaller CC and cerebral WM volumes than would be predicted from their ICV</p></caption><graphic id="d29e1707" xlink:href="41467_2018_5595_Fig2_HTML"></graphic></fig></p>
<p id="Par17">Apart from the reduced WM, significant differences were observed in the grey matter (GM) surface area and volume of several regions including decrease in right hemisphere (RH) lateral occipital surface area, RH isthmus cingulate, thalamus and left hemisphere (LH) postcentral surface area (TableÂ <xref ref-type="table" rid="Tab4">4</xref> and Fig.Â <xref ref-type="fig" rid="Fig2">2</xref>). The only region with more GM in carriers than noncarriers is the RH insula (TableÂ <xref ref-type="table" rid="Tab4">4</xref> and Fig.Â <xref ref-type="fig" rid="Fig2">2</xref>). The increased RH insula thickness may be comparable with the recent description of deep perisylvian/insular polymicrogyria on the right side, in a mother and child, both with a truncating mutation in <italic>MAP1B</italic> (Arg1106Ter), and diagnosed with periventricular nodular heterotopia (PVNH)<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>.<table-wrap id="Tab4"><label>Table 4</label><caption><p>Brain grey matter differences in <italic>MAP1B</italic> LoF carriers compared with controls</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Grey matter</th><th>MAP1B-FS</th><th>Controls-FS</th><th><italic>Î²</italic> (95% CI)</th><th>
<italic>P</italic>
</th></tr></thead><tbody><tr><td>RHâlateral occipitalâarea</td><td>3768.6 (336.8)</td><td>4813.9 (618.9)</td><td>â2.1 (â2.9, â1.3)</td><td>1.1âÃâ10<sup>â07</sup></td></tr><tr><td>RHâisthmus cingulateâvolume</td><td>1690.8 (287.0)</td><td>2406.6 (426.9)</td><td>â2.0 (â2.8, â1.3)</td><td>2.2âÃâ10<sup>â07</sup></td></tr><tr><td>Right thalamus properâvolume</td><td>6056.4 (720.9)</td><td>7099.5 (756.2)</td><td>â1.9 (â2.7, â1.2)</td><td>7.9âÃâ10<sup>â07</sup></td></tr><tr><td>Total thalamusâvolume</td><td>12720.9 (1506.2)</td><td>15006.4 (1608.0)</td><td>â1.9 (â2.7, â1.2)</td><td>1.1âÃâ10<sup>â06</sup></td></tr><tr><td>RHâsuperior parietalâvolume</td><td>10269.2 (1554.5)</td><td>12473.5 (1572.3)</td><td>â1.9 (â2.7, â1.1)</td><td>1.1âÃâ10<sup>â06</sup></td></tr><tr><td>LHâpostcentralâarea</td><td>3433.9 (387.5)</td><td>4193.3 (502.1)</td><td>â1.9 (â2.7, â1.1)</td><td>1.3âÃâ10<sup>â06</sup></td></tr><tr><td>RHâinsulaâthickness</td><td>3.3 (0.1)</td><td>3.0 (0.2)</td><td>ââââ1.9 (1.1, 2.6)</td><td>1.9âÃâ10<sup>â06</sup></td></tr><tr><td>RHâisthmus cingulateâarea</td><td>697.0 (83.3)</td><td>962.5 (165.6)</td><td>â1.9 (â2.6, â1.1)</td><td>2.0âÃâ10<sup>â06</sup></td></tr><tr><td>LHâsuperior parietalâvolume</td><td>10221.1 (1301.4)</td><td>12567.8 (1661.6)</td><td>â1.8 (â2.5, â1.0)</td><td>4.9âÃâ10<sup>â06</sup></td></tr><tr><td>RHâlingualâvolume</td><td>5014.4 (689.2)</td><td>6379.8 (911.4)</td><td>â1.8 (â2.6, â1.0)</td><td>5.3âÃâ10<sup>â06</sup></td></tr><tr><td>LHâpostcentralâvolume</td><td>7424.0 (727.9)</td><td>9164.1 (1327.5)</td><td>â1.7 (â2.5, â1.0)</td><td>9.3âÃâ10<sup>â06</sup></td></tr><tr><td>Left thalamus properâvolume</td><td>6664.5 (838.1)</td><td>7906.9 (930.3)</td><td>â1.7 (â2.5, â1.0)</td><td>1.1âÃâ10<sup>â05</sup></td></tr><tr><td>RHâlateral orbito frontalâarea</td><td>2247.6 (287.6)</td><td>2678.3 (312.4)</td><td>â1.7 (â2.4, â0.9)</td><td>1.9âÃâ10<sup>â05</sup></td></tr><tr><td>RHârostral middle frontalâarea</td><td>5043.1 (825.1)</td><td>5987.8 (778.0)</td><td>â1.7 (â2.4, â0.9)</td><td>2.2âÃâ10<sup>â05</sup></td></tr><tr><td>RHâlateral occipitalâvolume</td><td>9177.2 (1004.8)</td><td>11253.2 (1607.7)</td><td>â1.6 (â2.4, â0.9)</td><td>2.4âÃâ10<sup>â05</sup></td></tr><tr><td>LHâpericalcarineâarea</td><td>1025.0 (208.3)</td><td>1431.4 (240.6)</td><td>â1.6 (â2.4, â0.9)</td><td>2.5âÃâ10<sup>â05</sup></td></tr><tr><td>RHâsupramarginalâvolume</td><td>8493.2 (1189.4)</td><td>9937 (1474.5)</td><td>â1.6 (â2.4, â0.9)</td><td>3.5âÃâ10<sup>â05</sup></td></tr><tr><td>LHâprecuneusâvolume</td><td>7665.6 (1201.7)</td><td>9202.4 (1259.4)</td><td>â1.6 (â2.4, â0.8)</td><td>4.0âÃâ10<sup>â05</sup></td></tr><tr><td>LHâsuperior parietalâarea</td><td>4524.4 (632.9)</td><td>5480.6 (652.4)</td><td>â1.6 (â2.3, â0.8)</td><td>5.3âÃâ10<sup>â05</sup></td></tr><tr><td>LHâcaudal middle frontalâvolume</td><td>5046.0 (1235)</td><td>6265.4 (1168.2)</td><td>â1.6 (â2.3, â0.8)</td><td>5.6âÃâ10<sup>â05</sup></td></tr><tr><td>LHâcaudal middle frontalâarea</td><td>1872.9 (395.3)</td><td>2357.7 (386.6)</td><td>â1.6 (â2.3, â0.8)</td><td>6.9âÃâ10<sup>â05</sup></td></tr><tr><td>RHâsupramarginalâarea</td><td>3140.5 (543.8)</td><td>3717.1 (510.1)</td><td>â1.6 (â2.3, â0.8)</td><td>8.6âÃâ10<sup>â05</sup></td></tr><tr><td>LHâinferior temporalâarea</td><td>2853.9 (423.8)</td><td>3477.8 (467.4)</td><td>â1.5 (â2.3, â0.8)</td><td>8.8âÃâ10<sup>â05</sup></td></tr><tr><td>LHâinferior parietalâarea</td><td>3881.0 (729.8)</td><td>4648.8 (634.0)</td><td>â1.5 (â2.3, â0.7)</td><td>1.3âÃâ10<sup>â04</sup></td></tr><tr><td>RHâparsorbitalisâarea</td><td>675.0 (98.6)</td><td>778.9 (107.8)</td><td>â1.5 (â2.3, â0.7)</td><td>1.3âÃâ10<sup>â04</sup></td></tr><tr><td>LHâinferior parietalâvolume</td><td>10169.3 (1777.0)</td><td>12202.0 (1838.4)</td><td>â1.5 (â2.3, â0.7)</td><td>1.4âÃâ10<sup>â04</sup></td></tr><tr><td>RHâcaudal middle frontalâarea</td><td>1700.7 (328.7)</td><td>2199.7 (383.0)</td><td>â1.5 (â2.3, â0.7)</td><td>1.5âÃâ10<sup>â04</sup></td></tr><tr><td>RHâprecentralâarea</td><td>4096.8 (569.3)</td><td>4820.5 (574.8)</td><td>â1.5 (â2.3, â0.7)</td><td>1.6âÃâ10<sup>â04</sup></td></tr><tr><td>RHâlingualâarea</td><td>2548.2 (274.5)</td><td>3175.1 (396.4)</td><td>â1.5 (â2.2, â0.7)</td><td>1.7âÃâ10<sup>â04</sup></td></tr></tbody></table><table-wrap-foot><p>The MAP1B-FS and Control-FS are unadjusted mean and standard deviation (SD) MRI white matter volume (mm<sup>3</sup>) and grey matter volume (mm<sup>3</sup>), surface area (mm<sup>2</sup>) and thickness (mm) values derived from FreeSurfer (FS). Individualsâ FS values were inverse normal transformed and adjusted for sex, age, age<sup>2</sup>, scanner model and ICV where appropriate. The effect (<italic>Î²</italic> in SD) and <italic>P</italic>-value were calculated by comparing <italic>MAP1B</italic> LoF carriers (<italic>n</italic>â=â10; FAM1-B1,-C1,-C2,-D1,-D2,-D3, FAM2-H1,-J1,-J2, FAM3-L1) with controls (<italic>n</italic>â=â949) using a generalised least-squares regression with a varianceâcovariance matrix based on the kinship coefficient of each pair of individuals. See Supplementary DataÂ <xref ref-type="media" rid="MOESM3">1</xref> for the full list of 274 traits. Bonferroni significance level was set at 0.05/274â=â1.8âÃâ10<sup>â4</sup></p><p>LH: left hemisphere, RH: right hemisphere, SD: standard deviation, FS: FreeSurfer</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec9">
<title>Clinical MRI evaluation of MAP1B variant carriers</title>
<p id="Par18">We performed clinical MRI evaluation of the <italic>MAP1B</italic> LoF variant carriers described here and found nine to have periventricular heterotopia symptoms consistent with PVNH (Supplementary TableÂ <xref ref-type="media" rid="MOESM1">1</xref>). Furthermore, most of the carriers had unusual/asymmetric supratentorial brain anatomy, without any gross malformation except in one <italic>MAP1B</italic> LoF carrier (FAM1-C1) with isolated inferior vermian hypoplasia (Dandy-Walker variant). A common neurological symptom of PVNH is epilepsy. However, only one <italic>MAP1B</italic> LoF carrier, in our cohort, has diagnosed epilepsy (FAM1-D3).</p>
</sec>
<sec id="Sec10">
<title>FA in reduced WM volume</title>
<p id="Par19">Insight into WM microstructure can be deduced from diffusion tensor imaging (DTI)<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. Applying tract-based spatial statistic (TBSS) analysis to whole-brain diffusion data, from nine <italic>MAP1B</italic> LoF carriers compared to 181 controls, revealed an association with reduced FA in brain-wide WM tracts (Fig.Â <xref ref-type="fig" rid="Fig3">3a</xref>). The lower FA observed in <italic>MAP1B</italic> LoF carriers suggests that their axonal tracts are either of reduced integrity or disordered arrangement. We also evaluated a subset of the noncarrier controls with low CC or WM and found that their FA was only affected in the densest part of the CC (Fig.Â <xref ref-type="fig" rid="Fig3">3b</xref>). This suggests that the effect of the <italic>MAP1B</italic> LoF variants on FA may be more profound than a smaller WM volume would indicate.<fig id="Fig3"><label>Fig. 3</label><caption><p>Diffusion (TBSS) data mapping from <italic>MAP1B</italic> LoF carriers compared with controls. Rows one, two, and three show, respectively, axial, coronal, and sagittal aspects of brain (MNI coordinates: 1, â13, 19) where heat map (red/yellow) intensity represents a significant change in fractional anisotropy (FA). <bold>a</bold> We compared <italic>MAP1B</italic> LoF carriers (<italic>n</italic>â=â9) with three control groups (column i: normal range controls (<italic>n</italic>â=â181), column ii: controls with small CC volume (<italic>Î²</italic>â&lt;ââ1.5âSD, <italic>n</italic>â=â15), and column iii: controls with small WM volume (<italic>Î²</italic>â&lt;ââ1.5âSD, <italic>n</italic>â=â10)) and found the carriers to have significantly lower brain-wide FA compared with all three control groups. <bold>b</bold> To determine whether a smaller CC volume generally leads to a decrease in FA, we compared the, column (i) 15 controls with smaller CC with 166 normal range controls and, column (ii) the ten controls with smaller WM with 160 normal range controls and found a reduction in FA only in the densest part of the CC. Family wise error (FWE) corrected significance threshold of 0.05</p></caption><graphic id="d29e2412" xlink:href="41467_2018_5595_Fig3_HTML"></graphic></fig></p>
</sec>
<sec id="Sec11">
<title>Truncated MAP1B protein is stable</title>
<p id="Par20">To determine whether the three <italic>MAP1B</italic> variants can produce a truncated MAP1B protein, we transiently overexpressed plasmids, incorporating each of the LoF mutations or wild-type <italic>MAP1B</italic>, in HeLa cells. We used western blot analysis, with antibodies recognising either the N-terminal or a V5 tag ligated to the C-terminal end of <italic>MAP1B</italic>, and detected bands in the expected sizes demonstrating that stable truncated proteins are generated from all three LoF variants (Fig.Â <xref ref-type="fig" rid="Fig4">4</xref> and Supplementary FigureÂ <xref ref-type="media" rid="MOESM1">7</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><p>Western blot of antibody binding to wild-type and truncated MAP1B proteins. <bold>a</bold> An image, from the Odyssey system, where the colour coded infrared fluorescent signals from the 700ânm channel (V5 antibody signalâblue) and the 800ânm channel (MAP1B antibody signalâgreen) are taken from the same blot; cyan indicates where both antibody signals overlap. See Supplementary FigureÂ <xref ref-type="media" rid="MOESM1">7</xref> for the individual V5 and MAP1B antibody signal greyscale pictures. <bold>b</bold> A schematic diagram of what each band on the western blot represents in the context of protein size (heavy chain (HC), light chain 1 (LC1) and truncated proteins). <bold>c</bold> A schematic diagram of truncated MAP1B and an indication of whether the anti-V5 or anti-MAP1B antibodies bind the protein product. The wild-type HC is only recognised by the anti-MAP1B antibody (green), and the wild-type LC1 is only recognised by the anti-V5 antibody (blue), while both anti-MAP1B and anti-V5 antibodies bind to all three truncated protein products as they contain both the MAP1B (amino acids 6-31) and V5 tags (cyan bands in <bold>b</bold>). The red X indicates that the LC1 is not produced as a consequence of the MAP1B truncation. AB actin-binding domain, MTA microtubule assembly helping site, putative, MTB microtubule-binding domain</p></caption><graphic id="d29e2457" xlink:href="41467_2018_5595_Fig4_HTML"></graphic></fig></p>
</sec>
</sec>
<sec id="Sec12" sec-type="discussion">
<title>Discussion</title>
<p id="Par21">We used a family-based approach to find a LoF variant in <italic>MAP1B</italic> that associates with ID, GM and WM deficits and lower FA. The family-based approach scores coding-sequence variants, propagating in a pedigree, based on the predicted functional effect of the variant and disease co-segregation likelihood ratio. We estimated the genome-wide <italic>P</italic>-value using simulated segregation of coding variants, from the founders of a large sample of WGS Icelanders. Two additional stop-gain variants in <italic>MAP1B</italic> were found, in two independent families, which confirmed the association with cognitive impairments. A PGS-IQ is not significantly different in <italic>MAP1B</italic> carriers compared with controls, suggesting that the LoF variants are responsible for the IQ impairment.</p>
<p id="Par22">MAP1B (reviewed in Ref. <sup><xref ref-type="bibr" rid="CR31">31</xref></sup>) is a member of the microtubule binding family of proteins important for axonal growth and synapse maturation during brain development. <italic>MAP1B</italic> is primarily expressed in the neuronal soma, dendrites and axons where, during development, it is enriched in the axonal growth cone. In the adult brain <italic>MAP1B</italic> expression remains high in areas that retain plasticity, including olfactory bulb, hippocampus and cerebellum. MAP1B undergoes post-translational modification whereby it is cleaved into a heavy chain (HC) and a light chain (LC1) (Supplementary FigureÂ <xref ref-type="media" rid="MOESM1">1</xref>).</p>
<p id="Par23">Each MAP1B chain has microtubule and actin-binding domains that promote tubulin polymerisation and cross linking, and while we only established that our LoF variants could produce stable truncated protein, in-vitro studies have shown that similarly truncated MAP1B HC can promote microtubule assembly<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>.</p>
<p id="Par24">When phosphorylated, MAP1B maintains microtubules in a dynamic state required for growth cone-mediated axonal elongation. However, decreased MAP1B phosphorylation increases microtubule stability, leading to axon branching<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. The majority of phosphorylation sites, regulating axonal growth and branching, are located downstream of the E712KfsTer10 <italic>MAP1B</italic> variant<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. Loss of these sites, through MAP1B truncation, is therefore likely to result in impaired elongation and increased branching as neurites from mouse <italic>MAP1B</italic> null models demonstrate<sup><xref ref-type="bibr" rid="CR35">35</xref></sup> and is recapitulated in studies where a MAP1B kinase, glycogen synthase kinase 3Î² (GSK3Î²), a key regulator of axon growth and branching, is inhibited<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. This could explain the observed lower FA in carriers as increased axonal branching or disordered arrangement may appear as a decrease in WM tract directionality.</p>
<p id="Par25">The three <italic>MAP1B</italic> LoF mutations all result in absence of the LC1. LC1 has functions independent of the HC and separate from its role during neuronal development<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. For instance, LC1 regulates the addition and removal of AMPA-type glutamate receptors at excitatory synapses, which forms one of the mechanisms of synaptic plasticity<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. By forming immobile complexes, the LC1 traps AMPA receptors and limits intracellular vesicular trafficking within the dendritic shaft. Hence, a LoF mutation affecting the LC1 will prevent MAP1B from regulating and restricting the access of AMPA receptors to dendritic spines and the postsynaptic membrane. The <italic>MAP1B</italic> mutations, E712KfsTer10, E1032Ter and R1664Ter are therefore likely to affect the control of downregulation of synaptic transmission by increasing the availability of circulating neurotransmitter receptors<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. Synaptic plasticity is accepted as the cellular basis of learning and memory, and the loss of this regulatory action could, in part, explain the carriersâ cognitive impairments.</p>
<p id="Par26">Expression and function of <italic>MAP1B</italic> is regulated by products of genes that when mutated, or lost, also result in neurodevelopmental disorders, including ID syndromes. A trinucleotide expansion polymorphism in fragile X mental retardation 1 <italic>(FMR1)</italic>, results in the Fragile X syndrome (FXS), a common cause of ID<sup><xref ref-type="bibr" rid="CR6">6</xref></sup> and autism<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. <italic>FMR1</italic> codes for the fragile X mental retardation protein (FMRP), an RNA-binding protein and essential translation regulator of multiple genes during brain development, including <italic>MAP1B</italic><sup><xref ref-type="bibr" rid="CR38">38</xref></sup>.</p>
<p id="Par27">A recent study using FMR1-KO mice showed larger WM volume overall, mostly due to the larger CC<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. This is supported by a human MRI study of adult males with FXS<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. The loss of FMRP in fragile X neurons and consequent reduction in its translational suppression function leads to elevated MAP1B expression<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. This may be a contributing factor to the increased WM, which is consistent with the phenotypes observed in the FXS cases and the mouse FMR1-KO models.</p>
<p id="Par28">Chromosome 2p15p16.1 deletion syndrome, which harbours the zinc finger transcription factor <italic>BCL11A-L</italic>, is a rare genetic disorder characterised by physical and neurodevelopmental impairments, including ID, and structural brain abnormalities, including CC hypoplasia<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. Knockdown of <italic>BCL11A-L</italic>, downregulates expression of <italic>MAP1B</italic> and the axon-guidance receptor <italic>DCC</italic> (deleted in colorectal cancer), and induces axon branching, multi-axon formation, and dendrite outgrowth with suggestions that BCL11A-L plays an important role in neural circuit formation during development<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>.</p>
<p id="Par29">BCL11A-L and FMRP target numerous genes also important for neuronal development, and their loss affects <italic>MAP1B</italic> expression in opposite direction. However, it is clear that under- or over-connectivity can result in cognitive deficits and that <italic>MAP1B</italic> is a critical intermediary, demonstrated by the loss of BCL11A-L and FMRP.</p>
<p id="Par30">Further research is required to unravel the effects of the truncated MAP1B-HC and loss of one copy of LC1 on brain development and synaptic plasticity. We have shown that LoF mutations produce stable truncated MAP1B and that LoF carriers develop both a neurological deficit and a cognitive impairment phenotype providing a comprehensive description of a syndrome involving <italic>MAP1B</italic>. LoF variants in <italic>MAP1B</italic> are found at a frequency of ~1 in 10,000, in publicly available databases, which places it within the range of the more common, single gene causes of syndromic ID.</p>
</sec>
<sec id="Sec13">
<title>Methods</title>
<sec id="Sec14">
<title>Study population and cognitive assessment</title>
<p id="Par31">Samples, neuropsychological assessment and questionnaire data were collected as part of studies approved by the National Bioethics Committee in Iceland. Participants signed informed consent before buccal swabs or blood samples were drawn. Personal identifiers were encrypted by a third-party system overseen by the Icelandic Data Protection Authority<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>.</p>
<p id="Par32">Intellectual disability and autism diagnoses were assigned at the State Diagnostic and Counselling Centre (SDCC) using ICD10 criteria. Refer to Supplementary TableÂ <xref ref-type="media" rid="MOESM1">1</xref> for the Wechsler scale of intelligence available, from the SDCC, for each participant.</p>
<p id="Par33">Phenotypic assessment, at the Study Recruitment Centre, as applied previously<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, uses the Mini-International Neuropsychiatric Interview (M.I.N.I.)<sup><xref ref-type="bibr" rid="CR19">19</xref></sup> to assess psychiatric disorders and the Global Assessment of Functioning (GAF) to assess social and occupational functioning. The Icelandic version of the Wechsler Abbreviated Scale of Intelligence (WASI<sup>IS</sup>)<sup><xref ref-type="bibr" rid="CR44">44</xref>,<xref ref-type="bibr" rid="CR45">45</xref></sup>, which includes four subtests (Vocabulary, Similarities, Block Design and Matrix Reasoning), was administered to the <italic>MAP1B</italic> families and 1768 of the controls while another 458 controls were tested with two subtests, Vocabulary and Matrix Reasoning, from the Wechsler Adult Intelligence Scale (WAIS-III)<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. As Icelandic norms are unavailable for WAIS-III, these scores were combined with WASI<sup>IS</sup> scores using general cognitive ability (an extracted g factor) as an indicator of the comparability of the two control groups. We also applied the logical memory subtest (abbreviated LMI&amp;II) from the Wechsler Memory Scale III (WMS-III)<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>, the controlled oral word association test (COWAT; here called LF)<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>, the category naming test (here called category fluency)<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>, the Stroop test (name colour minus colour pad task abbreviated Stroop and Stroop black letter)<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>, the trail-making test (TMT (refers to part B minus part A) and TMT-A)<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>, the Wisconsin card-sorting test (WCST; perseverative error)<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>, as well as the spatial working memory<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>, rapid visual information processing<sup><xref ref-type="bibr" rid="CR54">54</xref></sup> and emotion recognition task (ERT; percentage correct and mean response latency<sup><xref ref-type="bibr" rid="CR55">55</xref>,<xref ref-type="bibr" rid="CR56">56</xref></sup> the last three are subtests of the Cambridge Neuropsychological Test Automated Battery (<ext-link ext-link-type="uri" xlink:href="http://www.cambridgecognition.com/">http://www.cambridgecognition.com/</ext-link>).</p>
<p id="Par34">As the ERT was not included in the previously published assessment<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, it will be briefly described here. The CANTAB ERT is a modified version of the Bristol University Emotional Recognition Task<sup><xref ref-type="bibr" rid="CR55">55</xref>,<xref ref-type="bibr" rid="CR57">57</xref></sup>. A computer morphed face (aggregated from 12 males) is presented on screen, for 200âms, expressing one of the six basic emotions (anger, disgust, fear, happiness, sadness or surprise)<sup><xref ref-type="bibr" rid="CR56">56</xref></sup> at a level of intensity from 1 (least) to 15 (most). This is followed by a six-button alternative forced-choice, whereby the participant is required to choose which emotion was displayed on the previous image. Each emotion intensity combination is presented either once, for a total of 90 images or in each of two sets of 90 images for a total of 180 responses (6 emotionsâÃâ15 intensitiesâÃâ2 rounds). Correct and incorrect responses and response time latency was recorded for each emotion intensity combination. ERT response time latency was averaged across the entire set of responses for an overall mean response latency and ERT correct responses were summed across all of the emotions and presented as a fraction of total number of correct responses, per individual.</p>
<p id="Par35">In total 13 <italic>MAP1B</italic> LoF carriers had some form of Wechsler scale of intelligence assessment. Where available, for the <italic>MAP1B</italic> LoF carriers, the WASI<sup>IS</sup> was used for calculations, followed by WISC-IV and WPPSI-R (See Supplementary TableÂ <xref ref-type="media" rid="MOESM1">1</xref>). Where PIQ was compared with VIQ using a one-sided, paired <italic>t</italic>-test, age and gender scaled IQ (mean of 100 and SD of 15) was used. Other IQ comparisons used IQ data that was inverse normally transformed. Values from the other cognitive tasks were inverse normally transformed, followed by adjustment for gender, age at assessment and age<sup>2</sup>, based on controls. Tests were standardised so that controls had a mean of zero and standard deviation of one and cognitive test scores arranged so that higher scores indicated greater impairment. To take the information on relatedness of the individuals into account, <italic>MAP1B</italic> LoF carriers (<italic>n</italic> varies per task, see TablesÂ <xref ref-type="table" rid="Tab1">1</xref> and <xref ref-type="table" rid="Tab2">2</xref>) were compared with controls (<italic>n</italic>â&gt;â2,200, see TablesÂ <xref ref-type="table" rid="Tab1">1</xref> and <xref ref-type="table" rid="Tab2">2</xref>) using generalised least-squares regression with a varianceâcovariance matrix based on the kinship coefficient of each pair of individuals (see Quantitative association replication and Reference<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>). To account for multiple comparisons, the Bonferroni correction was used, giving a significance threshold of <italic>P</italic>â=â0.05/20â=â2.5âÃâ10<sup>â3</sup> (seven WASI<sup>IS</sup> tests and 13 cognitive tests). We used RStudio (version 1.0.44; <ext-link ext-link-type="uri" xlink:href="https://www.rstudio.com/">https://www.rstudio.com/</ext-link>) integrating R (version 3.3.2; <ext-link ext-link-type="uri" xlink:href="https://www.r-project.org/">https://www.r-project.org/</ext-link>) for data handling and some analyses, psych package (version 1.16.12) for some summary statistics and ggplot2 (version 2.2.1) to generate some of the figures.</p>
</sec>
<sec id="Sec15">
<title>Sequencing</title>
<p id="Par36">Next-generation WGS, alignment and variant calling was carried out as described in ref. <sup><xref ref-type="bibr" rid="CR59">59</xref></sup>. In brief, DNA samples, isolated from blood or buccal swabs, were prepared using TruSeq DNA, TruSeq Nano or TruSeq PCR-Free kits as per Illuminas instructions. DNA was fragmented, end-repaired, size-selected and purified, followed by PCR enrichment and sequencing libraries were assessed for quality and concentration. Following hybridisation of sequencing libraries to flowcells using the Illumina cBot, Illumina GAIIx, HiSeq 2,000/2,500 or HiSeq X instruments were used to perform sequencing-by-synthesis on paired-end libraries followed by imaging and base-calling in real-time. All of the <italic>MAP1B</italic> carriers were sequenced on the HiSeq X instrument. Reads were aligned to NCBI Build 38 of the human reference sequence and then merged into a single BAM file, followed by multi-sample variant calling performed with GenomeAnalysisTK (GATK) version 2.3.9.</p>
<p id="Par37">Applied Biosystems BigDye Terminator v3.1 Cycle Sequencing Kit was used to confirm <italic>MAP1B</italic> LoF carrier status. PCR and cycle sequencing reactions were performed on MJ Research PTC-225 thermal cyclers. Applied Biosystems 3730xl DNA analyzers were used for signal detection.</p>
<p id="Par38">All positions reported are NCBI human genome build 38 unless otherwise stated.</p>
</sec>
<sec id="Sec16">
<title>Family-based association analysis</title>
<p id="Par39">We applied a recently described family-based method<sup><xref ref-type="bibr" rid="CR12">12</xref></sup> to test rare coding-sequence variants for disease segregation within the pedigree. In order to try and account for the extreme clustering of cases in the pedigree we directed our search towards high-penetrance coding variants carried by less than 30 whole-genome sequenced individuals. To test for association, we create a scoring function based on the effect of the coding variant, as well as its co-segregation with the disease, both inside and outside of the pedigree. Genome-wide simulations are then used to provide significance estimates.</p>
<p id="Par40">We used logistic regression, applying sex, year of birth, county of birth and lifespan as covariates in the whole dataset, to estimate the probability of individual <italic>i</italic> being affected: let <italic>A</italic><sub><italic>i</italic></sub> be the affection status of individual <italic>i</italic> and <italic>x</italic><sub><italic>i</italic></sub> be his covariates, then we estimate<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$f_i = {\rm{log}it}\left( {p\left( {A_i|x_i} \right)} \right),$$\end{document}</tex-math><mml:math display="block" id="M2"><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi mathvariant="normal">log</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>â£</mml:mo><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:math><graphic position="anchor" xlink:href="41467_2018_5595_Article_Equa.gif"></graphic></alternatives></disp-formula>or equivalently<disp-formula id="Equb"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p\left( {A_i|x_i} \right) = \frac{{{\mathrm e}^{f_i}}}{{1 + {\mathrm e}^{f_i}}}.$$\end{document}</tex-math><mml:math display="block" id="M4"><mml:mi>p</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>â£</mml:mo><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant="normal">e</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="normal">e</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:math><graphic position="anchor" xlink:href="41467_2018_5595_Article_Equb.gif"></graphic></alternatives></disp-formula></p>
<p id="Par41">Our analysis tests particular variants, in a known set of carriers, distinct from parametric linkage analysis which searches for linkage with unknown linkage variants. However, comparable to parametric linkage<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>, the variant being tested has an assumed effect.</p>
<p id="Par42">We assume that the genetic effect parameter <italic>Î²</italic>, for the genotype <italic>g</italic><sub><italic>i</italic></sub> of individual <italic>i</italic>, affects penetrance as follows:<disp-formula id="Equc"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\rm logit}\left( {p\left( {A_i\left| {g_i,x_i} \right.} \right)} \right) = f_i + \beta g_i$$\end{document}</tex-math><mml:math display="block" id="M6"><mml:mi mathvariant="normal">l</mml:mi><mml:mi>o</mml:mi><mml:mi>g</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mfenced close="" open="â£" separators=""><mml:mrow><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>Î²</mml:mi><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math><graphic position="anchor" xlink:href="41467_2018_5595_Article_Equc.gif"></graphic></alternatives></disp-formula>or equivalently<disp-formula id="Equd"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p\left( {A_i\left| {g_i,x_i} \right.} \right) = \frac{{{\mathrm e}^{f_i + \beta g_i}}}{{1 + {\mathrm e}^{f_i + \beta g_i}}}.$$\end{document}</tex-math><mml:math display="block" id="M8"><mml:mi>p</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mfenced close="" open="â£" separators=""><mml:mrow><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant="normal">e</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>Î²</mml:mi><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="normal">e</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>Î²</mml:mi><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:math><graphic position="anchor" xlink:href="41467_2018_5595_Article_Equd.gif"></graphic></alternatives></disp-formula></p>
<p id="Par43">We assumed <italic>g</italic><sub><italic>i</italic></sub> to be either 0 or 1 given the dominant mode of inheritance pattern of the cases. We used a peeling algorithm<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>, to calculate the likelihood of the observed cases and controls, and so to estimate the genetic effect of the supposed disease causing variant behind the familial clustering. We then obtained a maximum likelihood estimate of the genetic effect <italic>Î²</italic> by maximising the likelihood with a BroydenâFletcherâGoldfarbâShannon (BFGS) maximizer.</p>
<p id="Par44">We then applied the optimal test statistic, to test whether a genetic variant is causal or has no effect on disease, as stated by the likelihood ratio principle:<disp-formula id="Eque"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{array}{l}{\rm{LLR}} = \log \frac{{p\left( {A\left| {x,\beta = \hat \beta } \right.} \right)}}{{p\left( {A\left| {x,\beta = 0} \right.} \right)}} = \mathop {\sum }\limits_i \log \left( {p\left( {A_i\left| {g_i,x_i,\beta = \hat \beta } \right.} \right)} \right)\\ - \log \left( {p\left( {A_i\left| {g_i,x_i,\beta = 0} \right.} \right)} \right)\\ = \mathop {\sum }\limits_{i:A_i = 1} \log \left( {\frac{{{\mathrm e}^{f_i + \hat \beta g_i}}}{{1 + {\mathrm e}^{f_i + \hat \beta g_i}}}} \right) - \log \left( {\frac{{{\mathrm e}^{f_i}}}{{1 + {\mathrm e}^{f_i}}}} \right)\\ + \mathop {\sum }\limits_{i:A_i = 0} \log \left( {\frac{1}{{1 + {\mathrm e}^{f_i + \hat \beta g_i}}}} \right) - \log \left( {\frac{1}{{1 + {\mathrm e}^{f_i}}}} \right)\\ = \mathop {\sum }\limits_{i:A_i = 1} g_i\left( {\log \left( {\frac{{{\mathrm e}^{f_i + \hat \beta }}}{{1 + {\mathrm e}^{f_i + \hat \beta }}}} \right) - \log \left( {\frac{{{\mathrm e}^{f_i}}}{{1 + {\mathrm e}^{f_i}}}} \right)} \right)\\ + \mathop {\sum }\limits_{i:A_i = 0} g_i\left( {\log \left( {\frac{1}{{1 + {\mathrm e}^{f_i + \hat \beta }}}} \right) - \log \left( {\frac{1}{{1 + {\mathrm e}^{f_i}}}} \right)} \right) \cdot \end{array}$$\end{document}</tex-math><mml:math display="block" id="M10"><mml:mtable><mml:mtr><mml:mtd columnalign="left"><mml:mi mathvariant="normal">LLR</mml:mi><mml:mo>=</mml:mo><mml:mo> log</mml:mo><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mi>A</mml:mi><mml:mfenced close="" open="â£" separators=""><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>Î²</mml:mi><mml:mo>=</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi>Î²</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mi>A</mml:mi><mml:mfenced close="" open="â£" separators=""><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>Î²</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:munder><mml:mrow><mml:mo> â</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:munder><mml:mo> log</mml:mo><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mfenced close="" open="â£" separators=""><mml:mrow><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mi>Î²</mml:mi><mml:mo>=</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi>Î²</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="left"><mml:mo>-</mml:mo><mml:mo> log</mml:mo><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mfenced close="" open="â£" separators=""><mml:mrow><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mi>Î²</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="left"><mml:mo>=</mml:mo><mml:munder><mml:mrow><mml:mo> â</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>:</mml:mo><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:munder><mml:mo> log</mml:mo><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant="normal">e</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi>Î²</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="normal">e</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi>Î²</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced><mml:mo>-</mml:mo><mml:mo> log</mml:mo><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant="normal">e</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="normal">e</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="left"><mml:mo>+</mml:mo><mml:munder><mml:mrow><mml:mo> â</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>:</mml:mo><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:munder><mml:mo> log</mml:mo><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="normal">e</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi>Î²</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced><mml:mo>-</mml:mo><mml:mo> log</mml:mo><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="normal">e</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="left"><mml:mo>=</mml:mo><mml:munder><mml:mrow><mml:mo> â</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>:</mml:mo><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:munder><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mo>log</mml:mo><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant="normal">e</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi>Î²</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="normal">e</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi>Î²</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced><mml:mo>-</mml:mo><mml:mo> log</mml:mo><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant="normal">e</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="normal">e</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="left"><mml:mo>+</mml:mo><mml:munder><mml:mrow><mml:mo> â</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>:</mml:mo><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:munder><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mo>log</mml:mo><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="normal">e</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi>Î²</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced><mml:mo>-</mml:mo><mml:mo> log</mml:mo><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="normal">e</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>â</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math><graphic position="anchor" xlink:href="41467_2018_5595_Article_Eque.gif"></graphic></alternatives></disp-formula>While affected and unaffected carriers have a positive and negative impact, respectively, the log likelihood ratio terms are 0 for noncarriers. In order to avoid blanket removal of variants not unique to the pedigree and to upweigh variants present in affecteds outside the pedigree, we counted carriers outside the family in the score.</p>
<p id="Par45">We define the score for marker <italic>m</italic> as<disp-formula id="Equf"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\rm{LLR}}\left( m \right) - \log \left( {P\left( {{\mathrm{coding}}\,{\mathrm{effect}}\,{\mathrm{of}}\,m} \right)} \right) \cdot$$\end{document}</tex-math><mml:math display="block" id="M12"><mml:mi mathvariant="normal">LLR</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:mfenced><mml:mo>-</mml:mo><mml:mo> log</mml:mo><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mi>P</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mi mathvariant="normal">coding</mml:mi><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">effect</mml:mi><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">of</mml:mi><mml:mspace width="0.3em"></mml:mspace><mml:mi>m</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>â</mml:mo></mml:math><graphic position="anchor" xlink:href="41467_2018_5595_Article_Equf.gif"></graphic></alternatives></disp-formula>We are only considering coding variants and âlog (<italic>P</italic> (coding effect of <italic>m</italic>)) will be 2.96 higher for loss-of-function variants than moderate impact variants based on the frequencies of such coding mutations<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>.</p>
<p id="Par46">To estimate the significance of a variant we used genome-wide simulations, sampling founders from a set of 30âK whole-genome sequenced Icelanders outside of the pedigree and counting the number of times the highest score was equal to or higher than the observed score. From 100,000 simulations a distribution of the highest score for all markers in the genome could be generated and a genome-wide <italic>P</italic>-value estimated from the fraction of simulations with scores greater than or equal to the highest observed score. We took <italic>P</italic>â&lt;â0.05 to be significant.</p>
</sec>
<sec id="Sec17">
<title>Case control association replication</title>
<p id="Par47">Logistic regression was used to test for association between variants and disease, treating disease status as the response and genotype counts (alleles from either LoF variant) as covariates (explanatory variables). We also included sex, county of birth, current age or age at death (first and second order terms included), blood sample availability for the individual and an indicator function for the overlap of the lifetime of the individual with the timespan of phenotype collection as nuisance variables in the model.</p>
<p id="Par48">Given genotype counts for <italic>n</italic> individuals, <italic>g</italic><sub>1</sub>,<italic>g</italic><sub><italic>e</italic></sub>,â¦,<italic>g</italic><sub><italic>n</italic></sub>Ïµ{0,1,2}, their phenotypes <italic>y</italic><sub>1</sub>,<italic>y</italic><sub>2</sub>,â¦,<italic>y</italic><sub><italic>n</italic></sub>Ïµ{0,1} and a list of vectors of nuisance parameters <italic>x</italic><sub>1</sub>,<italic>x</italic><sub>2</sub>,â¦,<italic>x</italic><sub><italic>n</italic></sub>, the logistic regression model states that<disp-formula id="Equg"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$L_i\left( {\alpha ,\beta ,\gamma } \right) = P\left( {y_i = 1\left| {g_i,x_i} \right.} \right)$$\end{document}</tex-math><mml:math display="block" id="M14"><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mi>Î±</mml:mi><mml:mo>,</mml:mo><mml:mi>Î²</mml:mi><mml:mo>,</mml:mo><mml:mi>Î³</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mi>P</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mfenced close="" open="â£" separators=""><mml:mrow><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:math><graphic position="anchor" xlink:href="41467_2018_5595_Article_Equg.gif"></graphic></alternatives></disp-formula><disp-formula id="Equh"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\rm{logit}}\left( {P\left( {y_i = 1\left| {g_i,x_i} \right.} \right)} \right) = \alpha + \beta g_i + \gamma ^Tx_i,{\mathrm{for}}\,{\mathrm{all}}\,i \in \{ 1,2,...,n\} ,$$\end{document}</tex-math><mml:math display="block" id="M16"><mml:mi mathvariant="normal">logit</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mi>P</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mfenced close="" open="â£" separators=""><mml:mrow><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mi>Î±</mml:mi><mml:mo>+</mml:mo><mml:mi>Î²</mml:mi><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi>Î³</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi></mml:mrow></mml:msup><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">for</mml:mi><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">all</mml:mi><mml:mspace width="0.3em"></mml:mspace><mml:mi>i</mml:mi><mml:mo>â</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>,</mml:mo><mml:mi>n</mml:mi></mml:mrow><mml:mo>}</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:math><graphic position="anchor" xlink:href="41467_2018_5595_Article_Equh.gif"></graphic></alternatives></disp-formula>where <italic>Î±</italic>, <italic>Î²</italic> and <italic>Î³</italic> are the regression coefficients and <italic>L</italic><sub><italic>i</italic></sub> is the contribution of the <italic>i</italic> th individual to the likelihood function; <inline-formula id="IEq1"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$L\left( {\alpha ,\beta ,\gamma } \right) = \mathop {\prod }\limits_{i = 1}^n L_i\left( {\alpha ,\beta ,\gamma } \right)$$\end{document}</tex-math><mml:math id="M18"><mml:mi>L</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mi>Î±</mml:mi><mml:mo>,</mml:mo><mml:mi>Î²</mml:mi><mml:mo>,</mml:mo><mml:mi>Î³</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:munderover accent="false" accentunder="false"><mml:mrow><mml:mo> â</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:munderover><mml:msub><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mi>Î±</mml:mi><mml:mo>,</mml:mo><mml:mi>Î²</mml:mi><mml:mo>,</mml:mo><mml:mi>Î³</mml:mi></mml:mrow></mml:mfenced></mml:math><inline-graphic xlink:href="41467_2018_5595_Article_IEq1.gif"></inline-graphic></alternatives></inline-formula>. It is then possible to test for association based on the asymptotic assumption that the likelihood ratio statistic follows a <italic>Ï</italic><sup>2</sup> distribution with one degree of freedom:<disp-formula id="Equi"><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$2\log \left( {\frac{{\mathop {{\max }}\limits_{\alpha ,\beta ,\gamma } L(\alpha ,\beta ,\gamma )}}{{\mathop {{\max }}\limits_{\alpha ,\gamma } L(\alpha ,\beta = 0,\gamma )}}} \right) \sim \chi _1^2 \cdot$$\end{document}</tex-math><mml:math display="block" id="M20"><mml:mn>2</mml:mn><mml:mo>log</mml:mo><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mfrac><mml:mrow><mml:munder><mml:mrow><mml:mo>max</mml:mo></mml:mrow><mml:mrow><mml:mi>Î±</mml:mi><mml:mo>,</mml:mo><mml:mi>Î²</mml:mi><mml:mo>,</mml:mo><mml:mi>Î³</mml:mi></mml:mrow></mml:munder><mml:mi>L</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>Î±</mml:mi><mml:mo>,</mml:mo><mml:mi>Î²</mml:mi><mml:mo>,</mml:mo><mml:mi>Î³</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:munder><mml:mrow><mml:mo>max</mml:mo></mml:mrow><mml:mrow><mml:mi>Î±</mml:mi><mml:mo>,</mml:mo><mml:mi>Î³</mml:mi></mml:mrow></mml:munder><mml:mi>L</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>Î±</mml:mi><mml:mo>,</mml:mo><mml:mi>Î²</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mi>Î³</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced><mml:mo>~</mml:mo><mml:msubsup><mml:mrow><mml:mi>Ï</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>â</mml:mo></mml:math><graphic position="anchor" xlink:href="41467_2018_5595_Article_Equi.gif"></graphic></alternatives></disp-formula></p>
<p id="Par49">For the replication only whole-genome sequenced cases and controls were used; of those FAM2-J1 and J3 are case carriers and FAM2-H1,-J2 and FAM3-L1 are control carriers.</p>
</sec>
<sec id="Sec18">
<title>Quantitative association replication</title>
<p id="Par50">A generalised form of linear regression was used to test IQ for association with the variants.</p>
<p id="Par51">The regression model assumes a normal distribution of the quantitative measurements (<italic>y</italic>) with a mean that depends linearly on the expected allele (<italic>g</italic>) of the variant being tested and a varianceâcovariance matrix proportional to the kinship matrix:<disp-formula id="Equj"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{y}} \sim {{N}}\left( {{{\alpha + \beta g}},2{\mathrm{\sigma }}^2\phi } \right),$$\end{document}</tex-math><mml:math display="block" id="M22"><mml:mi>y</mml:mi><mml:mo>~</mml:mo><mml:mi>N</mml:mi><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mi>Î±</mml:mi><mml:mo>+</mml:mo><mml:mi>Î²</mml:mi><mml:mi>g</mml:mi><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:msup><mml:mrow><mml:mi mathvariant="normal">Ï</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mi>Ï</mml:mi></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:math><graphic position="anchor" xlink:href="41467_2018_5595_Article_Equj.gif"></graphic></alternatives></disp-formula>Where<disp-formula id="Equk"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\phi {{_i}{_j}} = \left\{ {\begin{array}{*{20}{c}} {\frac{1}{2},i = j} \\ {2k{_i}_j,i \ne j} \end{array}} \right.$$\end{document}</tex-math><mml:math display="block" id="M24"><mml:msub><mml:mrow><mml:mi>Ï</mml:mi><mml:msub><mml:mrow></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfenced close="" open="{" separators=""><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="center"><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mi>j</mml:mi></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="center"><mml:mn>2</mml:mn><mml:msub><mml:mrow><mml:mi>k</mml:mi><mml:msub><mml:mrow></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mi>i</mml:mi><mml:mo>â </mml:mo><mml:mi>j</mml:mi></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:math><graphic position="anchor" xlink:href="41467_2018_5595_Article_Equk.gif"></graphic></alternatives></disp-formula>is the kinship matrix as estimated from the Icelandic genealogical database.</p>
</sec>
<sec id="Sec19">
<title>Genetic analysis</title>
<p id="Par52">Microarray genotyping and long-range phasing was described previously<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>. Briefly, chip-typed samples are assayed with an Illumina bead chip at deCODE genetics. Chip SNPs are excluded based on a number of quality criteria, and samples with a call rate below 97% are not used.</p>
<p id="Par53">Long-range phasing to determine parent of origin was achieved as outlined in ref. <sup><xref ref-type="bibr" rid="CR63">63</xref></sup>. In brief, assigning the parent of origin was performed by identifying the closest relatives who shared a haplotype with the proband. Parental origin was then assigned to the two haplotypes of a proband on the basis of a computed score.</p>
</sec>
<sec id="Sec20">
<title>Computing IQ PGS and effect on IQ</title>
<p id="Par54">Summary statistics from a recent GWAS for IQ<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> and educational attainment<sup><xref ref-type="bibr" rid="CR24">24</xref></sup> provided the per-locus allele-specific weightings to calculate a PGS-IQ and PGS-EDU, respectively. The basic method used to process the genotype data for Icelanders, including imputations based on full-genome sequencing results, was described above and in Reference<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>. The markers and methods used to compute the PGS-IQ and PGS-EDU have previously been described for computing an educational attainment PGS in Kong et al<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. A framework set of â¼600,000 high-quality SNPs (not including any of the <italic>MAP1B</italic> LoF variants) covering the whole genome was used to compute PGS-IQ and PGS-EDU. We adjusted for linkage disequilibrium using LDpred<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. The linkage disequilibrium between markers was estimated using the Icelandic samples. We used Welch two sample t-test to compare PGS-IQ and PGS-EDU in <italic>MAP1B</italic> carriers (<italic>n</italic>â=â13) to controls (<italic>n</italic>â=â2,164) in R (stats version 3.3.2).</p>
</sec>
<sec id="Sec21">
<title>Magnetic resonance imaging acquisition</title>
<p id="Par55">Magnetic resonance imaging (MRI), previously described<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR64">64</xref></sup> but summarised here, was performed on two 1.5âT whole body scanners at RÃ¶ntgen Domus Medica, a Philips Achieva and a Siemens Magnetom Aera. Scans were done with a sagittal 3D fast T1-weighted gradient echo sequence (Philips Achieva: repetition time (TR)â=â8.6âms, echo time (TE)â=â4.0âms, flip angle (FA)â=â8Â°, 170 slices, slice thicknessâ=â1.2âmm, acquisition matrixâ=â192âÃâ192, field of view (FOV)â=â240âÃâ240âmm; Siemens Aera: repetition time (TR)â=â2400âms, echo time (TE)â=â3.54âms, flip angle (FA)â=â8Â°, 160 slices, slice thicknessâ=â1.2âmm, acquisition matrixâ=â192âÃâ192, field of view (FOV)â=â240âÃâ240âmm). Ten <italic>MAP1B</italic> LoF carriers (on the Siemens Magnetom Aera) and 949 control subjects were scanned (257 with the Siemens Magnetom Aera and 692 with the Philips Achieva). Prior to FreeSurfer analyses, T1-weighted image data was converted from DICOM to NIfTI format.</p>
<p id="Par56">Diffusion tensor image (DTI) data was acquired on the Siemens Magnetom Aera 1.5âT system. Diffusion-weighted echo planar imaging (EPI) was used. Three series of 12 non-co-linear gradient diffusion-weighted images at <italic>b</italic>â=â800âS/mm<sup>2</sup> and one non-weighted (<italic>b</italic>â=â0âS/mm<sup>2</sup>) image was acquired, for a total of 39 images. The parameters for each image were as follows: TRâ=â8600âms, TEâ=â60âms, 60 slices, slice thicknessâ=â2âmm, acquisition matrixâ=â120âÃâ120, FOVâ=â240âÃâ240âmm, resulting in data acquired with a 2âÃâ2âÃâ2âmm voxel resolution.</p>
</sec>
<sec id="Sec22">
<title>Clinical MRI evaluation</title>
<p id="Par57">Along with the sagittal 3D fast T1-weighted gradient echo sequence, scans were also done with an axial proton density T2-weighted turbo spin echo sequence (Siemens Aera: TRâ=â3000âms, TE-1â=â12âms, TE-2â=â96âms, FAâ=â150Â°, 48 slices, slice thicknessâ=â3âmm, acquisition matrixâ=â256âÃâ232, FOVâ=â240âÃâ240âmm). Prior to clinical assessment, T1- and T2-weighted image data was converted from DICOM to NIfTI format. The neuroradiologist was unaware of <italic>MAP1B</italic> LoF carrier status and was provided with equal numbers of noncarriers, prior to evaluating symptoms of periventricular nodular heterotopia. T1- and T2-weighted images were viewed using MRIcron version 12.12.2012 (<ext-link ext-link-type="uri" xlink:href="http://www.mricro.com">http://www.mricro.com</ext-link>).</p>
</sec>
<sec id="Sec23">
<title>Surface-based morphometry</title>
<p id="Par58">Segmentation and parcellation of the T1-weighted image data was performed with FreeSurfer V5.3.0 software (<ext-link ext-link-type="uri" xlink:href="http://freesurfer.net">http://freesurfer.net</ext-link>)<sup><xref ref-type="bibr" rid="CR65">65</xref></sup>. FreeSurfer automatically identifies cerebrospinal fluid (CSF), white matter (WM)<sup><xref ref-type="bibr" rid="CR66">66</xref></sup> and GM tissue in the brain and automatically segments and parcellates regions according to predefined atlases; cortical regions according to the Desikan/Killiany Atlas<sup><xref ref-type="bibr" rid="CR67">67</xref></sup> and subcortical regions according to the Fischl/Salat Atlas<sup><xref ref-type="bibr" rid="CR68">68</xref></sup>. FreeSurfer extracts region of interest (ROI) volumes (mm<sup>3</sup>) for all defined subcortical regions and cortical thickness (mm), surface area (mm<sup>2</sup>) and volume (mm<sup>3</sup>) for all cortical ROIs. This provided 104 Desikan/Killiany Atlas (times two for LH and RHs) cortical values for analysis. Combined values for certain volumes were also created. A total of 274 volumes, surface areas and thickness values were analysed (Supplementary DataÂ <xref ref-type="media" rid="MOESM3">1</xref>).</p>
<p id="Par59">Volume, surface area and cortical thickness values were inverse normally transformed, followed by adjustment for gender, age at scan, age<sup>2</sup>, scanner type and where applicable ICV, based on data from controls only; intracranial volume (ICV) was used as an adjustment variable for volume (except ICV was not adjusted for itself) and surface area, but not for thickness. To take the information on relatedness of the individuals into account, <italic>MAP1B</italic> LoF carriers (<italic>n</italic>â=â10) were compared with controls (<italic>n</italic>â=â949) using generalised least-squares regression with a varianceâcovariance matrix based on the kinship coefficient of each pair of individuals (see Quantitative association replication and Ref. <sup><xref ref-type="bibr" rid="CR58">58</xref></sup>). To account for multiple comparisons, the Bonferroni correction was used, giving a significance threshold of <italic>P</italic>â=â0.05/274â=â1.8âÃâ10<sup>â4</sup>.</p>
</sec>
<sec id="Sec24">
<title>Diffusion tensor imaging</title>
<p id="Par60">The diffusion-weighted data was preprocessed using the FMRIB Software Library (FSL)<sup><xref ref-type="bibr" rid="CR69">69</xref></sup>. First, FSLâs diffusion toolbox (FDT) was used for eddy current and motion correction, where the eddy currents are corrected with an affine registration to the b0 image and motion correction with a rigid body registration to b0. Second, non-brain areas were removed from the analysis using the BET tool<sup><xref ref-type="bibr" rid="CR70">70</xref></sup> from FSL. Finally, FDT was used to fit the tensors at each voxel and create FA maps for each subject.</p>
</sec>
<sec id="Sec25">
<title>Tract-based spatial statistical analysis</title>
<p id="Par61">Tract-based spatial statistics (TBSS) was used to perform voxel-wise statistical analysis of the FA data<sup><xref ref-type="bibr" rid="CR71">71</xref></sup>. FA data were aligned into a common space using the nonlinear registration tool FNIRT<sup><xref ref-type="bibr" rid="CR72">72</xref>,<xref ref-type="bibr" rid="CR73">73</xref></sup>, which uses a b-spline representation of the registration warp field<sup><xref ref-type="bibr" rid="CR74">74</xref></sup>, for all subjects. This was followed by creating a mean FA skeleton, which represents the centres of all tracts common to the group, from the thinned, mean FA image. Data, resulting from each subjectâs aligned FA data projected onto the mean FA skeleton, were then fed into voxel-wise cross-subject statistics.</p>
<p id="Par62">Multiple regression models that included age and gender as covariates of no interest were used to investigate the effect of <italic>MAP1B</italic> on FA. A comparison between controls and <italic>MAP1B</italic> subjects (CONTROLâ&gt;âMAP1B and MAP1Bâ&lt;âCONTROL) was performed. Additionally, <italic>MAP1B</italic> subjects were compared with CONTROLs with lower WM volume and CONTROLs with smaller CC. Statistical significance was assessed using FSLâs randomise function<sup><xref ref-type="bibr" rid="CR75">75</xref></sup> with the threshold-free cluster enhancement (TFCE). The significance assessment was based on 5000 random permutations and a corrected <italic>P</italic>â&lt;â0.05 was considered as significant.</p>
</sec>
<sec id="Sec26">
<title>Generation of MAP1B plasmid variants</title>
<p id="Par63">We obtained an ORF Flexi clone from Promega (product ID FXC02218) that contained full-length <italic>MAP1B</italic> cDNA (GenBank: NM_005909). From that clone, full-length <italic>MAP1B</italic> cDNA was amplified by PCR primers F-5â²ATGGCGACCGTGGTGGTGâ²3, R-5â²CAGTTCAATCTTGCATGCAGGGâ²3 and cloned into pcDNA3.1/V5-His TOPO vector (Invitrogen K4800-01) following manufacturers protocol resulting in pcDNA3.1_MAP1B_WT. Transformed TOP10 chemically competent cells (Invitrogen C4040-10) were plated on LB plates containing 100âÂµg/ml ampicillin. Colonies were expanded in LB medium containing 100âÂµg/ml ampicillin. Plasmids were purified using Monarch nucleic acid purification kit (New England Biolabs T1010L) following the manufacturers protocol. Plasmid sequence was confirmed by Sanger sequencing.</p>
<p id="Par64">In order to generate <italic>MAP1B</italic> cDNA variants E1032Ter and R1664Ter the pcDNA3.1_MAP1B_WT plasmid was used as a template. In short, a PCR reaction was performed using the following primers E1032Ter (F-5â²ATGGCGACCGTGGTGGTGâ²3, R-5â²CTCTCTGGCATCTTCAGCTTTGâ²3), and R1664Ter (F-5â²ATGGCGACCGTGGTGGTGâ²3, R-5â²ACTGAAGTCCATAGCAAGGGATâ²3) resulting in a double stranded DNA fragment representing the entire pcDNA3.1 plasmid and the first 1031, and 1663 amino acids of <italic>MAP1B</italic> for the E1032Ter, R1664Ter variants, respectively. The STOP codon of the pcDNA3.1 plasmid was utilised instead of the one encoded by the <italic>MAP1B</italic> variants in order to attach a 3â² V5-tag to the protein variants in case <italic>MAP1B</italic> antibodies would not be able to recognise the variant protein product.</p>
<p id="Par65">To generate the E712KfsTer10 variant, we first mutated the pcDNA3.1_MAP1B_WT plasmid using the Q5 site-directed mutagenesis kit (New England BioLabs E0554S) and the following primers (F-5â²AAGTTAAGAAGGAAGAGAAGâ²3, R-5â²CTTCTTGACTTCCTTTGGâ²3) generating pcDNA3.1_MAP1B_WT_2133delG. With this mutagenesis, the <italic>MAP1B</italic> protein will be correct from amino acid 1-711 followed by nine out of frame amino acids (KLRRKRRRK) plus a termination codon. We subjected this mutagenesis product to a PCR to get a template that contains the initiation codon of <italic>MAP1B</italic> in addition to the following 719 AA minus the stop codon using the following primers (F-5â²ATGGCGACCGTGGTGGTGâ²3, R-5â²CTTCCTTCTTCTCTTCCTTCTTAACâ²3). This template was then cloned into pcDNA3.1 in frame with the V5 tag as described for the <italic>MAP1B</italic> E1032Ter and R1664Ter mutations, resulting in pcDNA3.1_MAP1B_E712KfsTer10. The sequences of pcDNA3.1_MAP1B_E712KfsTer10, pcDNA3.1_MAP1B_E1032Ter, and pcDNA3.1_MAP1B_R1664Ter were confirmed by Sanger sequencing.</p>
</sec>
<sec id="Sec27">
<title>Expression of MAP1B in cultured cells</title>
<p id="Par66">One day prior to transfection, 320,000 HeLa cells (Public Health England 93021013) were seeded into each well of a 6-well plate in 3âmL of DMEM medium (11995-065, ThermoFisher) supplemented with 10% foetal calf serum (ThermoFisher 10500-064) and 50 units/mL penicillin and 50âÂµg/mL streptomycin (ThermoFisher 15070-063). On the day of transfection, media was replaced with the identical media as before without antibiotics. On the day of transfection, for each transfected well, 2.5âÂµg of pcDNA3.1_MAP1B_WT,pcDNA3.1_MAP1B_E712KfsTer10, pcDNA3.1_MAP1B_E1032Ter, or pcDNA3.1_MAP1B_R1664Ter plasmids were diluted in 125âÂµL Opti-Mem medium (ThermoFisher 31985- 047) and 5âÂµL of P3000 reagent (ThermoFisher L3000-008). Next, 5âÂµL Lipofectamine 3000 (ThermoFisher L3000-008) was mixed with 125âÂµL of Opti-Mem. Subsequently, the diluted plasmid solution was mixed with the Lipofectamine 3000 solution at a 1:1 ratio and incubated at room temperature for 12âmin before the addition of 250âÂµL of the combined solution to each transfected well. Forty-eight hours post transfection, cell media was changed to full media and 24âh later cells were harvested for analysis.</p>
</sec>
<sec id="Sec28">
<title>Western blot analysis</title>
<p id="Par67">Wells were washed 2Ã with PBS and cells corresponding to one well of a 6-well plate were lysed using 150âÂµl of RIPA buffer with 1:100 Halt protease and phosphatase inhibitor cocktail (Thermo Scientific 78442). Lysates were kept on ice for 10âmin with agitation followed by sonication for 1âmin (Branson 2510). Lysates were spun down at 4âÂ°C for 15âmin at 14,000Ã <italic>g</italic>. Total amount of protein lysates was estimated using BCA protein assay (Thermo Scientific 23227). Samples were prepared using Novex Bolt LDS sample buffer (Life technologies B0007) and Novex Bolt sample reducing agent (Life technologies B0009) and run on NuPage 3â8% Tris-Acetate gel (ThermoFisher EAO375BOX). Total protein amount per lane was 60âÂµg and HiMark Pre-stained HMW protein standard (ThermoFisher Cat: LC5699) was used to estimate protein size. Gel was run at a constant of 150âV for 1âhour. Proteins were transferred to a PVDF membrane using wet blot transfer (mini trans blot BioRad) at a constant 70âV for 3âhours. Membranes were allowed to dry and then hydrated with MeOH and MQ water before blotting. Membranes were blocked for 1âhour at room temperature using 3% BSA in 1Ã TBS. Primary antibodies used were Î±-<italic>MAP1B</italic> (Santa Cruz sc-365668) 1:500 (recognises amino acids 6-31) and Î±-V5 (R&amp;D MAB8926) 1:1000 incubated in blocking buffer with the addition of 0.1% Tween overnight atâ+â4âÂ°C. Secondary antibodies used were Î±-Rabbit 680RD (Li-Cor 926-68073) and Î±-Mouse 800CW (Li-Cor 926-32212) both 1:20,000 in TBSTâ+â0.01% SDS for 1âhour at room temperature. After washing the membrane, it was allowed to dry and then scanned using the Odyssey infrared imaging system (Li-Cor Biosciences). Anti-V5 and anti-MAP1B (amino acids 6-31) antibodies were visualised at 700ânm and 800ânm wavelengths, respectively.</p>
</sec>
<sec id="Sec29">
<title>URL</title>
<p id="Par68">For American Psychiatric Association (APA), see <ext-link ext-link-type="uri" xlink:href="https://psychiatry.org">https://psychiatry.org</ext-link>. For Exome Aggregation Consortium (ExAc), seeÂ <ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/gene/ENSG00000131711">http://exac.broadinstitute.org/gene/ENSG00000131711</ext-link>.</p>
</sec>
<sec id="Sec30">
<title>Data Availability</title>
<p id="Par69">Data from publicly available databases (ExAc, gnomAD, 1000Genomes, NCBI-dbSNP/VarView, EVS-ESP, DECIPHER) and from the Simons Simplex Collection approved researcher access, was presented in the main text and supplementary material of this publication, but not used in any analyses. The data used in the analyses for this publication are not publicly available due to information, contained within them, that could compromise research participant privacy. The authors declare that the data supporting the findings of this study are available within the article, its Supplementary Information and upon request.</p>
</sec>
</sec>
<sec sec-type="supplementary-material">
<title>Electronic supplementary material</title>
<sec id="Sec32">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41467_2018_5595_MOESM1_ESM.pdf"><caption><p>Supplementary Information</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41467_2018_5595_MOESM2_ESM.pdf"><caption><p>peer review file</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41467_2018_5595_MOESM3_ESM.pdf"><caption><p>Description of Additional Supplementary Files</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="41467_2018_5595_MOESM4_ESM.xlsx"><caption><p>Supplementary Data 1</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p><bold>Publisher's note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
</fn-group>
<sec>
<title>Electronic supplementary material</title>
<p><bold>Supplementary Information</bold> accompanies this paper at 10.1038/s41467-018-05595-6.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>We are grateful to the participants and we thank the psychologists, nurses and staff, in particular Berglind Eiriksdottir, at the Research Recruitment Center and technicians and staff at RÃ¶ntgen Domus. We also thank the staff at deCODE genetics core facilities and all our colleagues for their important contribution to this work. L.J. received support from the Swedish Society of Medicine, the Swedish Brain Foundation and Swedish Society for Medical Research. The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreementsâ no. 115008 (NEWMEDS) and no. 115300 (EUAIMS) of which resources are composed of EFPIA in-kind contribution and financial contribution from the European Unionâs Seventh Framework Programme (EU-FP7/2007-2013), EU-FP7 funded grant no. 602450 (IMAGEMEND) and EU funded FP7-People-2011-IAPP grant agreement no. 286213 (PsychDPC).</p>
</ack>
<notes notes-type="author-contribution">
<title>Author Contributions</title>
<p>G.B.W., O.G., G.S., V.K.E., G.A.J., S.S., D.F.G., M.O.U., E.S., H.S. and K.S. designed the study. G.B.W., O.G., G.A.J., U.U., A.k., L.J., M.S.N., A.L. and H.S. were involved in informatics and data management. G.B.W., V.K.E., G.A.J., E.S. and H.S. carried out cohort ascertainment, recruitment and phenotyping. A.d.J., A.Si. and A.s.J. performed the genotyping. A.B.A., A.L.L. and G.L.N. performed the laboratory experiments. G.B.W., O.G., M.I.M., M.O.U. and H.S. managed and analysed the MRI data. A.L. performed the MRI clinical assessment. G.B.W., O.G., G.S., S.S., A.F.G, P.S., M.F., A.I., D.F.G., M.O.U. and H.S. provided statistical methods and performed analyses. G.B.W., O.G., G.S., A.B.A., M.Z., D.F.G., M.O.U., H.S. and K.S. wrote the manuscript with contributions to the final version from all authors.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar1">
<title>Competing interests</title>
<p>G.B.W., O.G., G.S., A.B.A., G.A.J., S.S., A.F.G., M.I.M., U.U., A.L.L., A.d.J., A.Si., A.s.J., A.Sk., M.S.N., P.S., M.F., A.I., G.L.N., M.Z., D.F.G., M.O.U., H.S. and K.S. are employees of deCODE genetics/Amgen. The remaining authors declare no competing interests.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<mixed-citation publication-type="other">American Psychiatric Association<italic>. DSM-5</italic> 5th edn (American Psychiatric Association, Washington, DC, 2013).</mixed-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<mixed-citation publication-type="other">Buxbaum J. D. &amp; Hof, P. R.Â <italic>The Neuroscience of Autism Spectrum Disorders</italic>Â (Academic Press, Oxford, 2013).</mixed-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paul</surname>
<given-names>LK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Agenesis of the corpus callosum: genetic, developmental and functional aspects of connectivity</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2007</year>
<volume>8</volume>
<fpage>287</fpage>
<lpage>299</lpage>
<pub-id pub-id-type="doi">10.1038/nrn2107</pub-id>
<pub-id pub-id-type="pmid">17375041</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vissers</surname>
<given-names>LE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A de novo paradigm for mental retardation</article-title>
<source/>Nat. Genet.
          <year>2010</year>
<volume>42</volume>
<fpage>1109</fpage>
<lpage>1112</lpage>
<pub-id pub-id-type="doi">10.1038/ng.712</pub-id>
<pub-id pub-id-type="pmid">21076407</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reichenberg</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Discontinuity in the genetic and environmental causes of the intellectual disability spectrum</article-title>
<source/>Proc. Natl Acad. Sci. USA
          <year>2016</year>
<volume>113</volume>
<fpage>1098</fpage>
<lpage>1103</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1508093112</pub-id>
<pub-id pub-id-type="pmid">26711998</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vissers</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Gilissen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Veltman</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Genetic studies in intellectual disability and related disorders</article-title>
<source/>Nat. Rev. Genet
          <year>2016</year>
<volume>17</volume>
<fpage>9</fpage>
<lpage>18</lpage>
<pub-id pub-id-type="doi">10.1038/nrg3999</pub-id>
<pub-id pub-id-type="pmid">26503795</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Deciphering Developmental Disorders S.</collab>
</person-group>
<article-title>Prevalence and architecture of de novo mutations in developmental disorders</article-title>
<source/>Nature
          <year>2017</year>
<volume>542</volume>
<fpage>433</fpage>
<lpage>438</lpage>
<pub-id pub-id-type="doi">10.1038/nature21062</pub-id>
<pub-id pub-id-type="pmid">28135719</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Ligt</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diagnostic exome sequencing in persons with severe intellectual disability</article-title>
<source/>N. Engl. J. Med
          <year>2012</year>
<volume>367</volume>
<fpage>1921</fpage>
<lpage>1929</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa1206524</pub-id>
<pub-id pub-id-type="pmid">23033978</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilissen</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome sequencing identifies major causes of severe intellectual disability</article-title>
<source/>Nature
          <year>2014</year>
<volume>511</volume>
<fpage>344</fpage>
<lpage>347</lpage>
<pub-id pub-id-type="doi">10.1038/nature13394</pub-id>
<pub-id pub-id-type="pmid">24896178</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuen</surname>
<given-names>RKC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder</article-title>
<source/>Nat Neurosci
          <year>2017</year>
<volume>20</volume>
<fpage>602</fpage>
<lpage>611</lpage>
<pub-id pub-id-type="doi">10.1038/nn.4524</pub-id>
<pub-id pub-id-type="pmid">28263302</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Bokhoven</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Genetic and epigenetic networks in intellectual disabilities</article-title>
<source/>Annu Rev. Genet
          <year>2011</year>
<volume>45</volume>
<fpage>81</fpage>
<lpage>104</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-genet-110410-132512</pub-id>
<pub-id pub-id-type="pmid">21910631</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steinberg</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Truncating mutations in RBM12 are associated with psychosis</article-title>
<source/>Nat Genet
          <year>2017</year>
<volume>49</volume>
<fpage>1251</fpage>
<lpage>1254</lpage>
<pub-id pub-id-type="doi">10.1038/ng.3894</pub-id>
<pub-id pub-id-type="pmid">28628109</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<mixed-citation publication-type="other">Broitman, J. &amp; Davis, J. M.Â <italic>Treating NVLD in Children: Professional Collaborations for Positive Outcomes</italic>Â (Springer Science &amp; Business Media, Berlin, Germany, 2013).</mixed-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lek</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>
<source/>Nature
          <year>2016</year>
<volume>536</volume>
<fpage>285</fpage>
<lpage>291</lpage>
<pub-id pub-id-type="doi">10.1038/nature19057</pub-id>
<pub-id pub-id-type="pmid">27535533</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kojkowski</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Minshew</surname>
<given-names>NJ</given-names>
</name>
</person-group>
<article-title>Do individuals with high functioning autism have the IQ profile associated with nonverbal learning disability?</article-title>
<source/>Res. Autism Spectr. Disord.
          <year>2008</year>
<volume>2</volume>
<fpage>353</fpage>
<lpage>361</lpage>
<pub-id pub-id-type="doi">10.1016/j.rasd.2007.08.005</pub-id>
<pub-id pub-id-type="pmid">18516234</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paul</surname>
<given-names>LK</given-names>
</name>
</person-group>
<article-title>Developmental malformation of the corpus callosum: a review of typical callosal development and examples of developmental disorders with callosal involvement</article-title>
<source/>J. Neurodev. Disord.
          <year>2011</year>
<volume>3</volume>
<fpage>3</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="doi">10.1007/s11689-010-9059-y</pub-id>
<pub-id pub-id-type="pmid">21484594</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stefansson</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CNVs conferring risk of autism or schizophrenia affect cognition in controls</article-title>
<source/>Nature
          <year>2014</year>
<volume>505</volume>
<fpage>361</fpage>
<lpage>366</lpage>
<pub-id pub-id-type="doi">10.1038/nature12818</pub-id>
<pub-id pub-id-type="pmid">24352232</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bridgman</surname>
<given-names>MW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Facial emotion recognition in agenesis of the corpus callosum</article-title>
<source/>J. Neurodev. Disord.
          <year>2014</year>
<volume>6</volume>
<fpage>32</fpage>
<pub-id pub-id-type="doi">10.1186/1866-1955-6-32</pub-id>
<pub-id pub-id-type="pmid">25705318</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheehan</surname>
<given-names>DV</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10</article-title>
<source/>J. Clin. Psychiatry
          <year>1998</year>
<volume>59</volume>
<issue>Suppl 20</issue>
<fpage>22</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="pmid">9881538</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hall</surname>
<given-names>RC</given-names>
</name>
</person-group>
<article-title>Global assessment of functioning. A modified scale</article-title>
<source/>Psychosomatics
          <year>1995</year>
<volume>36</volume>
<fpage>267</fpage>
<lpage>275</lpage>
<pub-id pub-id-type="doi">10.1016/S0033-3182(95)71666-8</pub-id>
<pub-id pub-id-type="pmid">7638314</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plomin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>von Stumm</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>The new genetics of intelligence</article-title>
<source/>Nat. Rev. Genet
          <year>2018</year>
<volume>19</volume>
<fpage>148</fpage>
<lpage>159</lpage>
<pub-id pub-id-type="doi">10.1038/nrg.2017.104</pub-id>
<pub-id pub-id-type="pmid">29335645</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kong</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Selection against variants in the genome associated with educational attainment</article-title>
<source/>Proc. Natl Acad. Sci. USA
          <year>2017</year>
<volume>114</volume>
<fpage>E727</fpage>
<lpage>E732</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1612113114</pub-id>
<pub-id pub-id-type="pmid">28096410</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Savage</surname>
<given-names>JE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence</article-title>
<source/>Nat. Genet.
          <year>2018</year>
<volume>50</volume>
<fpage>912</fpage>
<lpage>919</lpage>
<pub-id pub-id-type="doi">10.1038/s41588-018-0152-6</pub-id>
<pub-id pub-id-type="pmid">29942086</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okbay</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome-wide association study identifies 74 loci associated with educational attainment</article-title>
<source/>Nature
          <year>2016</year>
<volume>533</volume>
<fpage>539</fpage>
<lpage>542</lpage>
<pub-id pub-id-type="doi">10.1038/nature17671</pub-id>
<pub-id pub-id-type="pmid">27225129</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vilhjalmsson</surname>
<given-names>BJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Modeling linkage disequilibrium increases accuracy of polygenic risk scores</article-title>
<source/>Am. J. Hum. Genet.
          <year>2015</year>
<volume>97</volume>
<fpage>576</fpage>
<lpage>592</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2015.09.001</pub-id>
<pub-id pub-id-type="pmid">26430803</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edelmann</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neuronal abnormalities in microtubule-associated protein 1B mutant mice</article-title>
<source/>Proc. Natl Acad. Sci. USA
          <year>1996</year>
<volume>93</volume>
<fpage>1270</fpage>
<lpage>1275</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.93.3.1270</pub-id>
<pub-id pub-id-type="pmid">8577753</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonzalez-Billault</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Perinatal lethality of microtubule-associated protein 1B-deficient mice expressing alternative isoforms of the protein at low levels</article-title>
<source/>Mol. Cell. Neurosci.
          <year>2000</year>
<volume>16</volume>
<fpage>408</fpage>
<lpage>421</lpage>
<pub-id pub-id-type="doi">10.1006/mcne.2000.0880</pub-id>
<pub-id pub-id-type="pmid">11085878</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meixner</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MAP1B is required for axon guidance and is involved in the development of the central and peripheral nervous system</article-title>
<source/>J. Cell Biol.
          <year>2000</year>
<volume>151</volume>
<fpage>1169</fpage>
<lpage>1178</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.151.6.1169</pub-id>
<pub-id pub-id-type="pmid">11121433</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heinzen</surname>
<given-names>EL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo and inherited private variants in MAP1B in periventricular nodular heterotopia</article-title>
<source/>PLoS Genet.
          <year>2018</year>
<volume>14</volume>
<fpage>e1007281</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1007281</pub-id>
<pub-id pub-id-type="pmid">29738522</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Bihan</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diffusion tensor imaging: concepts and applications</article-title>
<source/>J. Magn. Reson Imaging
          <year>2001</year>
<volume>13</volume>
<fpage>534</fpage>
<lpage>546</lpage>
<pub-id pub-id-type="doi">10.1002/jmri.1076</pub-id>
<pub-id pub-id-type="pmid">11276097</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Villarroel-Campos</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gonzalez-Billault</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>The MAP1B case: an old MAP that is new again</article-title>
<source/>Dev. Neurobiol.
          <year>2014</year>
<volume>74</volume>
<fpage>953</fpage>
<lpage>971</lpage>
<pub-id pub-id-type="doi">10.1002/dneu.22178</pub-id>
<pub-id pub-id-type="pmid">24700609</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bondallaz</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Barbier</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Soehrman</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Grenningloh</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Riederer</surname>
<given-names>BM</given-names>
</name>
</person-group>
<article-title>The control of microtubule stability in vitro and in transfected cells by MAP1B and SCG10</article-title>
<source/>Cell Motil. Cytoskelet.
          <year>2006</year>
<volume>63</volume>
<fpage>681</fpage>
<lpage>695</lpage>
<pub-id pub-id-type="doi">10.1002/cm.20154</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalil</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Dent</surname>
<given-names>EW</given-names>
</name>
</person-group>
<article-title>Branch management: mechanisms of axon branching in the developing vertebrate CNS</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2014</year>
<volume>15</volume>
<fpage>7</fpage>
<lpage>18</lpage>
<pub-id pub-id-type="doi">10.1038/nrn3650</pub-id>
<pub-id pub-id-type="pmid">24356070</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scales</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kraus</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Goold</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Gordon-Weeks</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>Nonprimed and DYRK1A-primed GSK3 beta-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons</article-title>
<source/>J. Cell Sci.
          <year>2009</year>
<volume>122</volume>
<fpage>2424</fpage>
<lpage>2435</lpage>
<pub-id pub-id-type="doi">10.1242/jcs.040162</pub-id>
<pub-id pub-id-type="pmid">19549690</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bouquet</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microtubule-associated protein 1B controls directionality of growth cone migration and axonal branching in regeneration of adult dorsal root ganglia neurons</article-title>
<source/>J. Neurosci.
          <year>2004</year>
<volume>24</volume>
<fpage>7204</fpage>
<lpage>7213</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2254-04.2004</pub-id>
<pub-id pub-id-type="pmid">15306655</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barnat</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The GSK3-MAP1B pathway controls neurite branching and microtubule dynamics</article-title>
<source/>Mol. Cell Neurosci.
          <year>2016</year>
<volume>72</volume>
<fpage>9</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1016/j.mcn.2016.01.001</pub-id>
<pub-id pub-id-type="pmid">26773468</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palenzuela</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MAP1B light chain modulates synaptic transmission via AMPA receptor intracellular trapping</article-title>
<source/>J Neurosci,
          <year>2017</year>
<volume>37</volume>
<fpage>9945</fpage>
<lpage>9963</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0505-17.2017</pub-id>
<pub-id pub-id-type="pmid">28904092</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santoro</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Bray</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>ST</given-names>
</name>
</person-group>
<article-title>Molecular mechanisms of fragile X syndrome: a twenty-year perspective</article-title>
<source/>Annu Rev. Pathol.
          <year>2012</year>
<volume>7</volume>
<fpage>219</fpage>
<lpage>245</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-pathol-011811-132457</pub-id>
<pub-id pub-id-type="pmid">22017584</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Lerch</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Doering</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Foster</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Ellegood</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Regional brain volumes changes in adult male FMR1-KO mouse on the FVB strain</article-title>
<source/>Neuroscience
          <year>2016</year>
<volume>318</volume>
<fpage>12</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2016.01.021</pub-id>
<pub-id pub-id-type="pmid">26794591</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hallahan</surname>
<given-names>BP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>In vivo brain anatomy of adult males with Fragile X syndrome: an MRI study</article-title>
<source/>Neuroimage
          <year>2011</year>
<volume>54</volume>
<fpage>16</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.08.015</pub-id>
<pub-id pub-id-type="pmid">20708694</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shimbo</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Haploinsufficiency of BCL11A associated with cerebellar abnormalities in 2p15p16.1 deletion syndrome</article-title>
<source/>Mol. Genet Genom. Med
          <year>2017</year>
<volume>5</volume>
<fpage>429</fpage>
<lpage>437</lpage>
<pub-id pub-id-type="doi">10.1002/mgg3.289</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuo</surname>
<given-names>TY</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Hsueh</surname>
<given-names>YP</given-names>
</name>
</person-group>
<article-title>Bcl11A/CTIP1 regulates expression of DCC and MAP1b in control of axon branching and dendrite outgrowth</article-title>
<source/>Mol. Cell. Neurosci.
          <year>2009</year>
<volume>42</volume>
<fpage>195</fpage>
<lpage>207</lpage>
<pub-id pub-id-type="doi">10.1016/j.mcn.2009.07.006</pub-id>
<pub-id pub-id-type="pmid">19616629</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gulcher</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Kristjansson</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gudbjartsson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Stefansson</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Protection of privacy by third-party encryption in genetic research in Iceland</article-title>
<source/>Eur. J. Hum. Genet
          <year>2000</year>
<volume>8</volume>
<fpage>739</fpage>
<lpage>742</lpage>
<pub-id pub-id-type="doi">10.1038/sj.ejhg.5200530</pub-id>
<pub-id pub-id-type="pmid">11039572</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<mixed-citation publication-type="other">Wechsler, D. <italic>Wechsler Abbreviated Scale of Intelligence</italic>Â (Pearson, London, UK, 1999).</mixed-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<mixed-citation publication-type="other">Gudmundsson E. <italic>Mat Ã¡ greind fullorÃ°inna: WASIIS</italic> (Menntamalastofnun, Reykjavik, Iceland, 2015).</mixed-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<mixed-citation publication-type="other">Wechsler, D.Â <italic>Wechsler Adult Intelligence ScaleÂ </italic>3rd edn (Harcourt Assessment, San Antonio, TX, 1997) .</mixed-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<mixed-citation publication-type="other">Wechsler, D. <italic>Wechsler Memory Scale</italic> (American Psychological Association, Washington, DC, 1997).</mixed-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benton</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schum</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Sivan</surname>
<given-names>AB</given-names>
</name>
</person-group>
<article-title>Multilingual aphasia examination: Norms for children</article-title>
<source/>Clin. Neuro.
          <year>1989</year>
<volume>3</volume>
<fpage>375</fpage>
<lpage>383</lpage>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname>
<given-names>JC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Consortium to Establish a Registry for Alzheimerâs Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimerâs disease</article-title>
<source/>Neurology
          <year>1989</year>
<volume>39</volume>
<fpage>1159</fpage>
<lpage>1165</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.39.9.1159</pub-id>
<pub-id pub-id-type="pmid">2771064</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stroop</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Studies of interference in serial verbal reactions</article-title>
<source/>J. Exp. Psychol.
          <year>1935</year>
<volume>18</volume>
<fpage>643</fpage>
<pub-id pub-id-type="doi">10.1037/h0054651</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reitan</surname>
<given-names>RM</given-names>
</name>
</person-group>
<article-title>Validity of the Trail Making Test as an indicator of organic brain damage</article-title>
<source/>Percept. Mot. Skills
          <year>1958</year>
<volume>8</volume>
<fpage>271</fpage>
<lpage>276</lpage>
<pub-id pub-id-type="doi">10.2466/pms.1958.8.3.271</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berg</surname>
<given-names>EA</given-names>
</name>
</person-group>
<article-title>A simple objective technique for measuring flexibility in thinking</article-title>
<source/>J. Gen. Psychol.
          <year>1948</year>
<volume>39</volume>
<fpage>15</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1080/00221309.1948.9918159</pub-id>
<pub-id pub-id-type="pmid">18889466</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Owen</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Downes</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Sahakian</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Polkey</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Robbins</surname>
<given-names>TW</given-names>
</name>
</person-group>
<article-title>Planning and spatial working memory following frontal lobe lesions in man</article-title>
<source/>Neuropsychologia
          <year>1990</year>
<volume>28</volume>
<fpage>1021</fpage>
<lpage>1034</lpage>
<pub-id pub-id-type="doi">10.1016/0028-3932(90)90137-D</pub-id>
<pub-id pub-id-type="pmid">2267054</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sahakian</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Warburton</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type</article-title>
<source/>Br. J. Psychiatry
          <year>1989</year>
<volume>154</volume>
<fpage>797</fpage>
<lpage>800</lpage>
<pub-id pub-id-type="doi">10.1192/bjp.154.6.797</pub-id>
<pub-id pub-id-type="pmid">2597885</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bamford</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Early effects of duloxetine on emotion recognition in healthy volunteers</article-title>
<source/>J Psychopharmacol
          <year>2015</year>
<volume>29</volume>
<fpage>634</fpage>
<lpage>641</lpage>
<pub-id pub-id-type="doi">10.1177/0269881115570085</pub-id>
<pub-id pub-id-type="pmid">25759400</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ekman</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>An argument for basic emotions</article-title>
<source/>Cogn. Emot.
          <year>1992</year>
<volume>6</volume>
<fpage>169</fpage>
<lpage>200</lpage>
<pub-id pub-id-type="doi">10.1080/02699939208411068</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adams</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Penton-Voak</surname>
<given-names>IS</given-names>
</name>
<name>
<surname>Harmer</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Munafo</surname>
<given-names>MR</given-names>
</name>
</person-group>
<article-title>Effects of emotion recognition training on mood among individuals with high levels of depressive symptoms: study protocol for a randomised controlled trial</article-title>
<source/>Trials
          <year>2013</year>
<volume>14</volume>
<fpage>161</fpage>
<pub-id pub-id-type="doi">10.1186/1745-6215-14-161</pub-id>
<pub-id pub-id-type="pmid">23725208</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Styrkarsdottir</surname>
<given-names>U</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Nonsense mutation in the LGR4 gene is associated with several human diseases and other traits</article-title>
<source/>Nature
          <year>2013</year>
<volume>497</volume>
<fpage>517</fpage>
<lpage>520</lpage>
<pub-id pub-id-type="doi">10.1038/nature12124</pub-id>
<pub-id pub-id-type="pmid">23644456</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jonsson</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Whole genome characterization of sequence diversity of 15,220 Icelanders</article-title>
<source/>Sci. Data
          <year>2017</year>
<volume>4</volume>
<fpage>170115</fpage>
<pub-id pub-id-type="doi">10.1038/sdata.2017.115</pub-id>
<pub-id pub-id-type="pmid">28933420</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lander</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Construction of multilocus genetic linkage maps in humans</article-title>
<source/>Proc. Natl Acad. Sci. USA
          <year>1987</year>
<volume>84</volume>
<fpage>2363</fpage>
<lpage>2367</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.84.8.2363</pub-id>
<pub-id pub-id-type="pmid">3470801</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elston</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>A general model for the genetic analysis of pedigree data</article-title>
<source/>Hum. Hered.
          <year>1971</year>
<volume>21</volume>
<fpage>523</fpage>
<lpage>542</lpage>
<pub-id pub-id-type="doi">10.1159/000152448</pub-id>
<pub-id pub-id-type="pmid">5149961</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gudbjartsson</surname>
<given-names>DF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Large-scale whole-genome sequencing of the Icelandic population</article-title>
<source/>Nat. Genet
          <year>2015</year>
<volume>47</volume>
<fpage>435</fpage>
<lpage>444</lpage>
<pub-id pub-id-type="doi">10.1038/ng.3247</pub-id>
<pub-id pub-id-type="pmid">25807286</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kong</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Parental origin of sequence variants associated with complex diseases</article-title>
<source/>Nature
          <year>2009</year>
<volume>462</volume>
<fpage>868</fpage>
<lpage>874</lpage>
<pub-id pub-id-type="doi">10.1038/nature08625</pub-id>
<pub-id pub-id-type="pmid">20016592</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ulfarsson</surname>
<given-names>MO</given-names>
</name>
<etal></etal>
</person-group>
<article-title>15q11.2 CNV affects cognitive, structural and functional correlates of dyslexia and dyscalculia</article-title>
<source/>Transl. Psychiatry
          <year>2017</year>
<volume>7</volume>
<fpage>e1109</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2017.77</pub-id>
<pub-id pub-id-type="pmid">28440815</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fischl</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>FreeSurfer</article-title>
<source/>Neuroimage
          <year>2012</year>
<volume>62</volume>
<fpage>774</fpage>
<lpage>781</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2012.01.021</pub-id>
<pub-id pub-id-type="pmid">22248573</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salat</surname>
<given-names>DH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Age-associated alterations in cortical gray and white matter signal intensity and gray to white matter contrast</article-title>
<source/>Neuroimage
          <year>2009</year>
<volume>48</volume>
<fpage>21</fpage>
<lpage>28</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2009.06.074</pub-id>
<pub-id pub-id-type="pmid">19580876</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Desikan</surname>
<given-names>RS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest</article-title>
<source/>Neuroimage
          <year>2006</year>
<volume>31</volume>
<fpage>968</fpage>
<lpage>980</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2006.01.021</pub-id>
<pub-id pub-id-type="pmid">16530430</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fischl</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain</article-title>
<source/>Neuron
          <year>2002</year>
<volume>33</volume>
<fpage>341</fpage>
<lpage>355</lpage>
<pub-id pub-id-type="doi">10.1016/S0896-6273(02)00569-X</pub-id>
<pub-id pub-id-type="pmid">11832223</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jenkinson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Beckmann</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Behrens</surname>
<given-names>TE</given-names>
</name>
<name>
<surname>Woolrich</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>FSL</article-title>
<source/>Neuroimage
          <year>2012</year>
<volume>62</volume>
<fpage>782</fpage>
<lpage>790</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2011.09.015</pub-id>
<pub-id pub-id-type="pmid">21979382</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>Fast robust automated brain extraction</article-title>
<source/>Hum. Brain Mapp.
          <year>2002</year>
<volume>17</volume>
<fpage>143</fpage>
<lpage>155</lpage>
<pub-id pub-id-type="doi">10.1002/hbm.10062</pub-id>
<pub-id pub-id-type="pmid">12391568</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>SM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data</article-title>
<source/>Neuroimage
          <year>2006</year>
<volume>31</volume>
<fpage>1487</fpage>
<lpage>1505</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2006.02.024</pub-id>
<pub-id pub-id-type="pmid">16624579</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<mixed-citation publication-type="other">Andersson, J. L. R., Jenkinson, M. &amp; Smith, S. <italic>Non-Linear Optimisation</italic>. Technical report TR07JA1 (FMRIB Centre, Oxford, UK, 2007).</mixed-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<mixed-citation publication-type="other">Andersson, J. L. R., Jenkinson, M. &amp; Smith, S. <italic>Non-Linear Registration aka Spatial Normalisation</italic>. Technical report TR07JA2 (FMRIB Centre, Oxford, UK, 2007).</mixed-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rueckert</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Nonrigid registration using free-form deformations: application to breast MR images</article-title>
<source/>IEEE Trans. Med. Imaging
          <year>1999</year>
<volume>18</volume>
<fpage>712</fpage>
<lpage>721</lpage>
<pub-id pub-id-type="doi">10.1109/42.796284</pub-id>
<pub-id pub-id-type="pmid">10534053</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winkler</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Ridgway</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Webster</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Nichols</surname>
<given-names>TE</given-names>
</name>
</person-group>
<article-title>Permutation inference for the general linear model</article-title>
<source/>Neuroimage
          <year>2014</year>
<volume>92</volume>
<fpage>381</fpage>
<lpage>397</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2014.01.060</pub-id>
<pub-id pub-id-type="pmid">24530839</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>